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1 Summary 
This transnational and interdisciplinary research project builds on the knowledge and experience 
gathered in recent years by researchers from different scientific disciplines in six EU-countries: Ger-
many, Hungary, Ireland, the Netherlands, Poland and Portugal. 
 
The main methods applied in this project were an inventory of the NPS situation within each of the six 
countries and a survey among three groups of NPS users. 
 
For the inventory of the NPS situation in each of the six participating countries, national information 
was gathered from existing sources about NPS definitions, drug policy and legislative frameworks, 
supply (procurement and market), demand (prevalence rates, description of users, motives and pat-
terns of use) and prevention activities. In addition, eight experts were interviewed on these themes, 
with a focus on best practice. 
 
The survey was conducted among three groups of regular NPS users (as indicated by current 
knowledge), using a targeted sampling methodology: 
1. Socially marginalised users are ‘high risk drug users’, often also frequently using opioids, 
(crack)cocaine and or (meth)amphetamine – intravenous use or through smoking. They were 
recruited face-to-face by trained fieldworkers or care professionals in the street, at or through 
care and treatment facilities (e.g. drug services, shelters) and through snowball sampling. In 
most cases, pen-and-paper questionnaires were interviewer-administered; 
2. Users in night life are recreational drugs users who frequent clubs, raves and/or festivals. 
They were mainly recruited face-to-face on-site at clubs, raves and festivals. Users in night 
life mostly self-completed either a pen-and-paper or online questionnaire to which they were 
referred by a flyer containing a link and an individual code; 
3. Users in online communities are users who are very active on the internet, and actively partic-
ipate in drug forums. They were recruited by posting messages on drug-related social media 
and internet forums. Users in online communities were only given access to the online ques-
tionnaire. 
 
The survey was restricted to (1) recent NPS users (at least once in the past 12 months), (2) residents 
of the participating countries, and (3) adult (18+) users. The final sample consists of 3,023 recent NPS 
users, among which the online community sample is the largest and the marginalised sample the 
smallest. 
Subsample sizes per country broadly reflect the countries’ composition of the NPS users population 
(the Netherlands and Portugal have limited numbers of marginalised NPS users), differences in will-
ingness to cooperate among night life venues and online drug forums, and – in the case of Ireland – 
inaccessibility of night life because of Ethic Committee regulations. 
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 MARGINALISED NIGHT LIFE ONLINE TOTAL 
SAMPLE     
Germany 23 98 542 663 
Hungary 101 15 156 272 
Ireland 48 3 11 62 
The Netherlands 1 189 1,000 1,190 
Poland 86 172 338 596 
Portugal 7 170 63 240 
TOTAL 266 647 2,110 3,023 
 
A general result from both the inventory and the survey is a lack of a clear definition of NPS across 
and within countries. Experts often refer to the international UNODC or EMCDDA definitions, but at 
the same time complain of the limited workability of these definitions in everyday life. Legality is part 
of some definitions used but not others. When legality is taken into account, the NPS status of indi-
vidual substances depends on (and varies with) the prevailing laws of the countries. Regardless of 
definitions, the term NPS is virtually unknown among users. They use terms like ‘designer drugs’ or 
‘legal highs’ or a variety of synonyms (e.g. crystals, herbals). Other results are summarized by re-
search question in the following paragraphs. 
 
1.1 NPS USE 
 
What is the extent of NPS use (prevalence rates for different NPS), which substances are used 
within each group and what are patterns of use (frequency, poly drug use)? 
 
Estimating general population prevalence rates of NPS, or even prevalence rates among subgroups 
(e.g. young adults) within the general population, was beyond the scope of this study. Unachievable 
numbers of respondents would have had to be recruited for reliable measurement and to obtain a 
large enough sample of users to be able to study use characteristics. The survey was therefore re-
stricted to recent (last 12 months) users of NPS. As a consequence, the prevalence of different cate-
gories of NPS found in this study cannot be extrapolated to the broader populations of marginalised 
people, night life visitors or members of drug-related internet forums. Results do indicate, however, 
the relative proportion of users of specific categories of NPS, and similarities and differences therein 
between marginalised, night life and online community users and between countries. For comparison, 
Figure 1 and Figure 2 show prevalence rates of last 12 month use of five categories of NPS studied 
per group of users and per country. 
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Figure 1 Last 12 month use of categories of NPS among marginalised, night life and online community 
recent NPS users 
 
 
Within all samples of recent users of NPS in this study, branded stimulants (‘bath salts’) and/or stimu-
lants obtained pure were used by most. However, marginalised users reported using Młot Thora and 
Snow Blow most often, while night life and online community users most often reported using 4-FA 
and 4-MMC (mephedrone). 
Marginalised users also differ from night life and online community users by a higher prevalence of 
herbal blends and/or synthetic cannabinoids use. Moreover, while brands of herbal blends used are 
similar across the three groups (Mocarz, Spice and Bonzai are often named), marginalised users 
more often seem unaware that the active ingredients in many of these blends are synthetic canna-
binoids. 
Another difference between marginalised users and night life and online community users is the high-
er prevalence of psychedelic NPS use in the latter two. The types of psychedelics used does not differ 
much: NBOME’s and 2C-B are often named in all three groups. 
Online community users distinguish from both marginalised and night life users by relatively high lev-
els of benzodiazepine class NPS. 
Where the three groups of recent users in this study do not differ, is in their use of dissociative NPS 
(often MXE). 
 
Figure 2 Last 12 month use of categories of NPS among recent NPS users in six countries 
 
 
One could suspect that prevalence rates per country reflect the composition of the countries’ samples. 
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the Portuguese sample consists mainly of night life users and samples of Germany and the Nether-
land of online community users. However, results show differences between countries regardless of 
sample composition. 
 The use of herbal blends and/or pure synthetic cannabinoids is most prevalent in Hungary and 
Poland and least prevalent in the Netherlands; 
 Branded and/or pure stimulants are favoured by Dutch NPS users and are least popular in Portu-
gal; 
 The Portuguese and German samples are distinguished by high levels of psychedelic NPS use; 
 And as for dissociative and other NPS, Germany showed the highest prevalence rates and Ire-
land the lowest. 
 
Frequency of NPS use is often limited to a few times a month at the most; only the marginalised sam-
ple contains significant groups of daily users. Compared to the other categories of NPS, herbal blends 
and/or synthetic cannabinoids are used more frequently. 
Among night life and online community users, NPS are most often used in night life venues in the 
company of others, and NPS are mostly swallowed, smoked of snorted. In contrast, marginalised 
users most often use in public spaces, also use alone and often inject their NPS. 
Marginalised users also differ from night life and online community users in reporting substantially 
more acute unpleasant side effects (including paranoia and aggression), more mid- and long-term 
mental and physical problems and more social problems from NPS use. 
 
1.2 NPS USERS 
 
Who are the users of NPS? What are their demographic characteristics and drug use histo-
ries? 
 
In most countries, experts distinguish two main groups of NPS users: (1) socially integrated, recrea-
tional, experimental users, and (2) socially marginalised, problematic (intravenous) drug users. In the 
Netherlands, however, NPS does not seem to have surfaced in the street scene and the group of 
marginalised NPS users is virtually non-existent. In Portugal, the phenomenon of marginalised NPS 
users appears to be restricted to the islands of Madeira and the Azores, where traditional drugs are 
more expensive. 
 
The survey results show that recent NPS users in all countries are predominantly male (less than one 
third female). Online community users are mostly young adults between 18 and 25 years (average 
23.6 years). Night life users are somewhat older: between 18 and 35 years (average 25.7 years). 
Most night life users reside in large towns, but online community users often live in small and medi-
um-sized towns. Levels of education are high among both night life and online community users and 
many are students. 
Marginalised users of NPS are older than the other two samples (average 33.5 years). They are pre-
dominantly found in large towns, have had little education and are often unemployed. 
 
A history of drug use other than NPS is common among marginalised, night life and online community 
users. The majority of all samples of NPS users has ever used cannabis and traditional stimulant 
drugs (amphetamines, ecstasy and cocaine) and many have also used other drugs like magic mush-
rooms, lsd or ketamine. In comparison to the other two samples, marginalised users show higher life 
time prevalence of crack cocaine, heroin, methamphetamine and unprescribed downer medicines. 
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They also show considerably higher levels of intravenous drug use (which is rare among night life and 
online community users). 
 
1.3 SUPPLY 
 
How do users procure NPS? From/with friends, from traditional supply sources or through the 
internet? In case of the internet: which websites? 
 
Most recent NPS users from the survey purchase NPS themselves, but especially night life users also 
get NPS for free (through people sharing with them more often than getting it as a gift), have friends 
purchase NPS with their money or make a group-purchase. When purchasing NPS, marginalised 
users most often do this from a private dealer, night life users from a friend and online community 
users from the internet. Buying from stone-and-mortar shops (headshops or smartshops) is also re-
ported, but by a minority of users. Webshops dedicated to NPS are most often used to buy NPS 
online, social media and Darknet vendors were far less often mentioned. 
 
Depending on the country (laws and regulations), webshop and dealer, NPS are sold under their 
chemical name, a generic name (e.g. crystals, herbals), a ‘fake’ name (e.g. bath salt, plant food), a 
brand name (e.g. Spice, Snow Blow), or under the name of a traditional drug (e.g. ecstasy, lsd). As a 
result, many users do not know exactly what NPS they have used. 
 
A paper is being prepared in which gathered information on NPS markets, supply and procurement is 
analysed more elaborately. 
 
1.4 MARKET 
 
What are the market dynamics? Are NPS used because they are relatively easily available? Do 
people use NPS because it is difficult to procure other –preferred– types of drugs? Are NPS 
used as an alternative to, or in addition to controlled drugs? 
 
In Ireland, Hungary and the Netherlands the (most recent) wave of NPS started with an increase of 
mephedrone in 2009/2010. From there on, market developments differed. In Ireland the closure of 
headshops selling NPS in 2010 reportedly reduced NPS use. In Hungary supply has shifted to other 
cathinones (4-MEC, MDPV, pentedrone, alpha-PVP), accompanied by a rise in the seizures of plant 
material impregnated with synthetic cannabinoids. In the Netherlands, mephedrone never much 
caught on and is by now completely overshadowed by the increasingly popular 4-FA. In Germany the 
NPS phenomenon started in 2008/2009 with other synthetic stimulants (TFMPP and BZP), after which 
the focus shifted to synthetic cannabinoids, and more recently developed into a highly diversified NPS 
market. In Poland and Portugal, NPS market developments are strongly linked to the proliferation of 
stone-and-mortar NPS shops (various types of outlets in Poland, smartshops in Portugal) from around 
2008 and the consecutive ban of these shops in 2010 and 2013, respectively. 
 
Availability and affordability were often pointed out by experts as predominant motives for NPS use, 
especially among marginalised users. Shortages (resulting in higher prices) of traditional drugs were 
mentioned in Poland and the Portuguese islands. Inversely, the varied and accessible range of can-
nabis through coffeeshops is viewed as an important factor in the lack of enthusiasm for synthetic 
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cannabinoid variants in the Netherlands. Higher potency in comparison to (or failing quality of) con-
ventional drugs also play a role in some countries. In the Netherlands, the expansion of the NPS mar-
ket in 2009 was strongly associated with a (temporary) slump in the ecstasy market. Nowadays, how-
ever, it is not the poor quality, but the very high purity of ecstasy that explains why 4-FA is said to be 
popular in the Netherlands. Among survey respondents, marginalised users expressed a stronger 
motivation because of poor quality and low availability of other drugs than night life and online com-
munity users. 
 
Concerning the use of NPS in relation to the use of other substances, this report includes figures of 
life time use of other traditional drugs. Further analyses of recent/current use of these substances will 
yield some indication whether NPS use is supplementary of substitutional. 
 
1.5 PREVENTION 
 
What are best practices in NPS prevention regarding supply reduction and demand reduction? 
What role does the legality or illegality of NPS play in procurement and use? (e.g. deterrence) 
Do users apply strategies to avoid detection or arrest? 
 
In all countries, supply reduction is regulated by prohibiting NPS. In most cases NPS are individually 
scheduled, requiring the laws to be amended regularly, but Germany recently outlawed the entire 
NPS classes of phenethylamines and synthetic cannabinoids. In Ireland, Poland and Portugal, stone-
and-mortar shops selling NPS have been closed down. In addition, in the Netherlands the national 
smartshop organisation discouraged the sale of 4-FA even when it was still legal. 
Also for demand reduction the policies in the different countries are very much linked to the policies 
for other drugs. Information campaigns for NPS specifically are rare, although in some countries pro-
fessionals and peers are trained to provide information on (one or more) NPS. 
Most countries do not have general prevention programmes focusing on NPS specifically. That being 
said, in Poland there was one initiative on social media targeting a specific. In Ireland, as well, there 
was a general prevention programme for NPS, this time including more than one substance. 
For harm reduction it is even more true that NPS strategies are embedded in existing harm reduction 
activities that primarily target other substances. No harm reduction activities for NPS specifically have 
been developed. Exceptions to this rule are Dutch peer information projects targeting 4-FA, and a 
Germany listing the ingredients found in NPS. 
In none of the countries are treatment facilities aimed specifically at NPS users. However, NPS users 
are welcome in existing facilities. 
 
The general consensus among experts from all participating countries is that NPS users are not 
strongly guided by the legal status of the substances. There are, however, subgroups of users who 
are motivated by the non-detectability of NPS in common urine controls. This can hold for drug users 
who are in some form of drug control program (e.g. abstinence treatment) or people at risk of losing 
their driving licence or work permit. In the survey, alleged legality and non-detectability were among 
the least often reported motives for NPS use. 
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2 Introduction 
New Psychoactive Substances (NPS) are a rapidly growing group of psychoactive drugs. European 
Monitoring Centre for Drugs and Drug Addiction (EMCDDA) defines NPS as “synthetic or naturally 
occurring substances that are not controlled under international law, and often produced with the in-
tention of mimicking the effects of controlled drugs”. NPS are also a heterogeneous group (e.g. 
phenethylamines, tryptamines, cathinones and synthetic cannabinoids). The emergence of NPS pos-
es several challenges to EU legislators and law enforcement. 
 
Firstly, because the rapid spread and the strong variety in chemical composition, it is not an easy task 
to keep up with the emergence of NPS. This impedes timely and appropriate actions regarding the 
legal status of NPS, not only at the EU level, but also for individual EU member states, in particular if 
detailed (national) Risk Assessments are required in order to decide whether or not, and how a spe-
cific NPS should be regulated. 
Secondly, the emergence of NPS goes hand in hand with the internet as a growing marketplace. The 
internet is of growing importance as a source of information about NPS (e.g. chemical composition, 
psychoactive effects), not only for users but also for NPS producers and suppliers, thereby creating 
new market opportunities. Buying NPS through the internet generally does not require access to so-
cial networks and personal contacts with dealers, as is the case in traditional supply (e.g. in the street; 
in clubs; through ‘stone and mortar’ suppliers such as smart shops and in private settings). 
Thirdly, the transnational character of this new market significantly impacts on the structure and or-
ganisation of the NPS supply chain since geographical distances covered are much larger than be-
fore, while at the same time there are fewer intermediaries in the chain. 
 
Member states provide EU institutions (EMCDDA, Europol) with data about NPS, such as seizures; 
purity; fatal and non-fatal accidents; pharmacology and toxicology et cetera (e.g. from National Focal 
Points; police; customs; forensic institutes). Such information is highly relevant for monitoring the NPS 
market and for Risks Assessments. However, there is a need to be better informed about the extent 
and patterns of NPS use. Previous studies provided European-wide information, but this is not very 
specific (e.g. prevalence rates of NPS as a general category in Eurobarometer). Other research fo-
cussed on one type/category of NPS (e.g. Spice) or on only one group of users (e.g. night life settings 
or online communities) – and in the latter case often in only one European country. In addition, there 
is a need to better understand the supply side of the NPS market. There is a growing body of 
knowledge about the role of the internet in the NPS market (e.g. number and kinds of websites and 
types of NPS offered), but relatively little about the extent to which users buy NPS through the inter-
net, and the profile of buyers. Finally, there is a need for evidence-based best practices in the preven-
tion of NPS supply and demand. 
 
Current knowledge on NPS users indicates that three main groups can be distinguished that use NPS 
regularly: 
1. Socially marginalised users: ‘high risk drug users’, often also frequently using opioids, 
(crack)cocaine and or (meth)amphetamine – intravenous use or through smoking; often un-
employed, homeless and/or in care. 
2. Users in night life: recreational drugs users who frequent clubs, raves and/or festivals; they 
are likely to be mostly student and/or employed. 
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3. Users in online communities: users who are very active on the Internet and actively partici-
pate in drug forums. 
Current knowledge also suggests both similarities and differences between these groups and across 
EU countries with regards to user characteristics; (types of) NPS used; patterns of use; and procure-
ment (e.g. role of internet). Reasons for users to procure NPS through a specific source are as of yet 
largely unknown. Market dynamics might differ substantially from those of controlled drugs. 
 
This project aims to address the need to be better informed about the extent and patterns of NPS 
supply and use - in particular the role of the internet - and best practices in prevention of NPS supply 
and demand. 
The main objectives are: 
1. Determine the extent and patterns of NPS use amongst socially marginalised users, users in 
night life settings and users in online communities; 
2. Assess the characteristics of NPS users in these three groups; 
3. Collect information about supply; 
4. Identify market dynamics for NPS; 
5. Assess perception of legal status of NPS; 
6. Make an inventory of prevention strategies used in the different countries; 
7. Identify best practices; 
8. Disseminate and share project results Europe-wide. 
 
This transnational and interdisciplinary research project builds on the knowledge and experience 
gathered in recent years by researchers from different scientific disciplines in six EU-countries: Ger-
many, Hungary, Ireland, the Netherlands, Poland and Portugal. These six countries vary in NPS use 
prevalence known so far (e.g. Eurobarometer 2014), geographical location, groups known to use NPS 
and regulations in place for NPS. The research focussed on five themes: 
1. What is the extent of NPS use (prevalence rates for different NPS), which substances are 
used within each group and what are patterns of use (frequency, poly drug use)? 
2. Who are the users of NPS? What are their demographic characteristics and drug use histo-
ries? 
3. Supply: How do users procure NPS? From/with friends, from traditional supply sources or 
through the internet? In case of the internet: which websites? 
4. What are the market dynamics? Are NPS used because they are relatively easily available? 
Do people use NPS because it is difficult to procure other –preferred– types of drugs? Are 
NPS used as an alternative to, or in addition to controlled drugs? 
5. What are best practices in NPS prevention regarding supply reduction and demand reduc-
tion? What role does the legality or illegality of NPS play in procurement and use? (e.g. deter-
rence) Do users apply strategies to avoid detection or arrest? 
 
The European Drugs Strategy 2013-2020 specifically mentions the rapid rise of new drugs among 
young people and the difficulties policy makers have in responding to new drug trends. The infor-
mation collected in this project will provide important novel insights into the NPS market. These in-
clude the identification of similarities and differences in NPS use and supply across EU-countries and 
between user groups. It will also close the gap in knowledge about impact of current strategies aimed 
at reducing the supply/distribution and demand and use of NPS and allow for new perspectives on 
these chosen strategies as they relate to the reduction of health and social risks. 
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The main methods applied in this project were an inventory of the NPS situation; prevention activities 
and best practice within each of the six countries and a survey among the three groups of NPS users. 
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3 Inventory 
For the inventory of the NPS situation in each of the six participating countries, national information 
was gathered from existing sources about NPS definitions; drug policy and legislative frameworks; 
supply (procurement and market); demand (prevalence rates, description of users, motives and pat-
terns of use) and prevention activities. In addition, eight experts were interviewed on these themes, 
with a focus on best practice. This resulted in the publication of six Country reports on New Psychoac-
tive Substances and six National Reports on New Psychoactive Substances Expert Interviews, re-
flecting the NPS situation per country in 2016.
1
 Below is a concise summary of the information pre-
sented in these reports, including any changes that occurred after the reports were first completed. 
For details about the sources of the information presented below, we refer to the respective reports. 
3.1 DEFINITIONS 
3.1.1 Germany 
The most broadly used definition of NPS in Germany is that of the EMCDDA. However, when trying to 
define if and when a substance is ’new’, different criteria were mentioned. The level of the scientific 
knowledge was important especially for research experts. Furthermore, the quantitative relevance is 
important for defining a psychoactive substance as ‘new’ in the sense of a measurable increase of 
prevalence, even a short term one, the substance itself can be known for a longer time. For some a 
listing as a controlled substance is not sufficient to lose its status as ‘new’, but according to a regula-
tory definition, NPS cannot be traditional drugs in the sense of German legislation (Betäubungsmit-
telgesetz, BtmG) and vice versa. 
3.1.2 Hungary 
According to the Hungarian Medicine Act, new psychoactive substances are substances or groups of 
compounds recently appearing on the market that have no medicinal use and that, due to their effect 
on the central nervous system, are suitable for altering a person’s state of consciousness, behaviour 
or senses, and therefore represent a threat to public health similar to the substances listed in the illicit 
drug and psychotropic substance schedules. Experts, however, had difficulty in defining NPS and 
reported not to have a scientific or common definition for it. They do not approach the definitions of 
NPS by chemical structures of substances; they are more interested in effects, the symptoms and the 
social circumstances of the NPS usage. Among users, several synonyms (designer drugs, NPS, 
herbals) and names (‘zene’ (music), ‘kristály’ (crystal), ‘biofű’ (bioweed)) are used, but even if it’s the 
same name, they can have very different effects on the user. 
3.1.3 Ireland 
Definitions of NPS in Ireland vary within the context of the expert’s professional role, and are general-
ly confined within the regulatory domain and Irish legislative context. Some refer to the international 
The United Nations Office on Drugs and Crime (UNODC)definitions. Many label NPS within the con-
text of the headshops prior to 2010 and define ‘headshop’ legal highs or define NPS according to the 
psychoactive effect. Others refer to NPS as substances not detected in usual urine screening of drug 
treatment patients. Challenges in definition centre on detection, and verification of content by chemi-
                                                     
1
 These reports can be downloaded from the NPS-t website: www.npstransnational.org. 
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cal analysis. Because of the dynamic nature of the designer NPS market, surveillance and detection 
struggle to tackle continuously adapted products. 
3.1.4 The Netherlands 
Several different definitions of NPS are used in the Netherland. The legal status of a substance is 
sometimes part of the definition, other times not. To users, the term NPS is virtually unknown; they 
speak of designer drugs, legal highs or simply mention the formula. Also among experts, there is no 
consensus about the definition of NPS. Justice commonly define NPS by them not being scheduled in 
the national Opium Act (which makes 2C-B not a NPS) and police adhere to international UNODC 
definitions (according to which 4-FA is not a NPS, but ketamine is). Healthcare and prevention ex-
perts generally use more flexible definitions and consider lack of knowledge about health risks more 
important than legal status. 
3.1.5 Poland 
The legal definition of NPS in Poland is that of a substitute: a product comprising at least one new 
psychoactive substance or other substance with similar effects on central nervous system which can 
be used instead of a narcotic drug or psychotropic substance or the same purposes as a narcotic 
drug or psychotropic substance. 
The popular Polish term used to express the notion on NPS is ‘dopalacze’ which can be literally trans-
lated as ‘afterburners’ as it signifies the potential boost or a high one can get after NPS use. The term 
‘dopalacze’ comes from the name of the popular e-shop www.dopalacze.com launched in 2008, offer-
ing a vast catalogue of substances and products including herbal mixtures; powders; pills and crys-
tals. Media discourse also delivered several different labels describing the phenomenon as ‘legal 
highs’; ‘smart drugs’; ‘novel psychoactive substances’; ‘new generation drugs’; ‘designer drugs’ or 
‘research chemicals’ (Dobrowska, Bujalski 2013). The use of the Polish translation of the term NPS 
(‘Nowe Substancje Psychoatywne’) occurs mostly in a professional discourse and is not common 
among users and lay people. 
NPS are defined in opposition to conventional drugs as leading to greater (and fast increasing) harm. 
Their use is more risky because of unknown composition. Experts mentioned the inability to define 
NPS as it is impossible to create a closed register of NPS because of the emergence of new sub-
stances. 
According to experts the concept of new psychoactive substances includes both scheduled substanc-
es but also those substances that potentially can be scheduled in the future. Attention was drawn to 
the definitional problems associated with the unclear status of the substances, which have been pre-
sent for many years on the market and are already well recognized, such as mephedrone. 
NPS are defined as a relatively new phenomenon lacking the cultural contexts, meaning and symbolic 
value, typical for conventional drugs. NPS are treated instrumentally, without any social, political or 
moral consideration, contrary to conventional drugs that used to be considered as a manifestation of 
counter culture. 
3.1.6 Portugal 
Until the definition set by the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 
and the United Nations Office on Drugs and Crime (UNODC), the public and main definition of NPS 
was simply ‘legal drugs’, which encouraged and required an urgent national and institutional definition 
for these drugs. The governmental Directorate for Intervention on Addictive Behaviours and Depend-
encies (SICAD) adopted the EMCDDA definition in 2012 which was published in several media. 
Though most experts tend to follow regulatory definitions rather than scientific ones, there is no con-
sensus about the definition of NPS. There are definitions which only consider NPS as substances that 
have emerged recently. There are others which consider NPS as research chemicals, i.e. synthesized 
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substances. And yet others define NPS as substances that appeared recently in the market and be-
gan to be consumed recreationally, including ‘the new consumption of old substances’. Despite differ-
ences in definitions, most deliberately emphasize the ‘new’ instead of the ‘legal’. 
3.2 POLICY AND LEGISLATION 
3.2.1 Germany 
There are three lists of classified substances in the German narcotics law (BtMG): One (list III) defines 
all medicines that can be prescribed by doctors; the other two define all substances that may not be 
prescribed, making them ‘illegal’ for most (list II), if not all purposes (list I). Drug use is generally not 
criminalised in Germany but the possession of even small amounts of drugs is subject to criminal law. 
According to a clause in the BtMG, the state attorneys usually dismiss the charge if the case refers to 
a small amount of illicit drugs for personal use. Since 2009, there have been repeated amendments of 
the BtMG that banned (single) NPS. Since 2010, there were attempts to ban the sales of NPS by laws 
that regulate the market for pharmaceuticals (Medicinal Products Act, ‘Arzneimittelgesetz’, AMG) 
without criminalising the users. At the end of 2016, generic legislation (NpSG – Neue psychoactive 
Substanzen Gesetz) was implemented. The previous draft bill was ratified; therefore, on the 26th of 
November, 2016, phenethylamines and synthetic cannabinoids (cannabimimetics) were outlawed by 
defining groups of chemical molecules. Other groups of substances are not (yet) included. The law 
mainly aims at reducing the supply of NPS. While possession for personal use is also outlawed, the 
law does not include penalties or fines for this offense. However, it is (still) unclear whether this de-
criminalisation may be undermined by punishing users that bought NPS on the internet (incitement of 
supply, ‘Anstiftung zum Inverkehrbringen’). 
3.2.2 Hungary 
The Hungarian Criminal Code (effective from 2013) regulates illicit drugs under six statutory defini-
tions: drug trafficking; possession of narcotic drugs; inciting substance abuse; aiding in the manufac-
ture or production of narcotic drugs; criminal offences with drug precursors and misuse of new psy-
choactive substances. The Medicines Act (2005) lays down the framework of the new legislation, 
while the Government Decree (2012) determines the processes and the responsible institutions in 
connection with the reporting of new psychoactive substances; their preliminary assessment; their 
scheduling and risk assessment. The Medicines Act and the Government Decree created a new 
schedule (2014) for the new psychoactive substances which contains both individual compounds and 
compound groups (through this providing both a list of individual compounds and a generic ap-
proach). 
3.2.3 Ireland 
The current National Drug Strategy was designed as cross cutting area of public policy and service 
delivery and brings together Departments, agencies and the community and voluntary sectors to pro-
vide a collective response to tackling the drugs problem in the Republic of Ireland. The overall objec-
tive of the Strategy is to tackle the harm caused to individuals, families and communities by problem 
drug and alcohol use through five pillars: 
 Supply reduction 
 Prevention 
 Treatment 
 Rehabilitation and 
 Research. 
The primary legislation controlling drugs are the Misuse of Drugs Act 1977 and the Misuse of Drugs 
Act 1984. These are further amended by the Criminal Justice Act 1999, the Criminal Justice Act 2006 
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and the Criminal Justice Act 2007. The Misuse of Drugs Regulations 1988 (SI 328 of 1988) (as 
amended) registers the different substances to which the legislation applies and has two main pur-
poses. First, to establish a control system over specific substances so as to protect the public from 
dangerous or possibly dangerous or harmful substances. Second, it enables safe use of specific con-
trolled substances which, even though they can be harmful if misused, has a therapeutic and medical 
significance. As per this legislation, unless specifically authorised to do so, it is illegal to possess, 
supply, manufacture, import or export a controlled substance (for example stimulants, cannabinoids, 
or hallucinogens). NPS are regulated both by individual listing and a generic system. 
Street based headshops were blamed for the apparent extent of NPS use, mostly amongst youths, in 
the Republic of Ireland. Media attention and public reaction were the key factors that contributed to 
legislative controls over cathinones and a multitude of other NPS in the Republic of Ireland in May 
2010. Several headshop products in Ireland were made illegal on 23 August 2010 when the new 
Criminal Justice (Psychoactive Substances) Act 2010 was passed. This gave the Irish police and the 
Irish courts the power to prohibit sales of psychoactive substances in the case that such substances 
were not listed on under the Misuse of Drugs Act, or if they were represented on their packaging as 
‘not for human consumption’, which is often the case. It was explicitly aimed at vendors/suppliers and 
it was an endeavour that forced the closure of Irish headshops. 
3.2.4 The Netherlands 
The Dutch drug policy is a combination of judicial control and socio-medical control. Dutch legislation 
is laid down in the Opium Act, making possession and selling (but not use) of banned substances 
individually named on Schedule I (‘hard drugs’) or Schedule II (‘soft drugs’) illegal. 2C-B has been 
scheduled since 1997. In recent years, about a dozen NPS have been added to the Opium Act, for 
instance mephedrone (October 2011), 4-MA (February 2013), MXE (March 2015) an methylone (July 
2015). The most recent additions to Schedule I were 4-FA, alpha-pvp and acetylfentanyl (May 2017). 
3.2.5 Poland 
New Psychoactive Substances are regulated by the Polish Act of 29 July 2005 on Counteracting Drug 
Addiction. The list of illicit substances is specified in annexes to the Act which are updated when new 
substances are detected on the market. Until March 2009, NPS were legal, and the law did not regu-
late their status, yet the first amendment to the Act was implemented to expand the list of substances 
under the control of the State. The list included substances such as benzopiperazine (BZP), opioid 
receptor agonists and 15 plants, recognized to be the most common ingredients of NPS. In 2010 and 
2011 legislative actions against NPS became more intense. At that time three amendments were 
adopted. Two of them expanded the catalogue of illicit drugs. The first one from 2010 penalized sub-
stances mainly from the group of synthetic cannabinoids and mephedrone. The amendment from 
2011 expanded the catalogue by another 23 substances detected in NPS available on the market. In 
the amendment from 2010, in addition to the expansion of the list of illegal substances, NPS were 
defined as a substitute drug, banned the “advertising and promotion of food or other products by sug-
gesting that they have effects of psychotropic substances, narcotic drugs or their consumption, even 
against the intended use” and banned manufacturing and introducing NPS onto the market. The 
amendment from 2015 extended the list of scheduled substances again and banned the import of 
NPS from other countries. With the latest amendment from January 2016, in Poland there are 423 
scheduled psychoactive substances in total. 
3.2.6 Portugal 
NPS appeared in Portugal in 2007 with greater awareness from 2011 onwards. These substances 
were sold through smartshops throughout the country. It was the autonomous region of Madeira that 
first initiated a legislation related with NPS (October 2012), a legislative decree prohibiting the sale 
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and distribution of NPS. In 2012 an amendment to the national Decree-law No. 15/93 added some 
NPS – including mephedrone – to the illegal substances list and the Ministry of Health started working 
with Parliament in order to create a new national legislation able to control the entry and sale of NPS 
in Portugal. In 2013 the Decree-Law Nº 54/2013 was introduced and the Ordinance 154/2013 of the 
same date, outlawing over 159 new drugs and closing approximately 60 smartshops in Portugal. 
3.3 SUPPLY 
3.3.1 Germany 
Different NPS groups have emerged in Germany. At first (2008/2009), synthetic stimulants were dom-
inant, especially substitutes for amphetamine and MDMA, namely TFMPP and BZP. Then the focus 
shifted to synthetic cannabinoids and finally the phenomenon reached the point when the supply was 
highly diversified, in a way, that not only some stimulants and psychedelics occurred, but also opioids 
and benzodiazepines. 
The effects and side-effects of the new law that was implemented in 2016 are not yet clear. The re-
duced criminalisation of users is certainly a plus that may influence the criminalisation of possession 
of illegal drugs for personal consumption in general. While there might be a noticeable reduction of 
supply in general, it is questionable whether the law will have the desired effects, especially with re-
gard to problematic NPS use. Furthermore, the first synthetic cannabinoid that is not covered by the 
chemical definition that is used in the NpSG has already occurred on the market (MDA 19). Sellers 
have immediately reacted and now claim to sell only substances that are not banned by the NpSG. 
Subsequently, there seems to be a higher risk that benzodiazepines and synthetic opioids are traded 
unless these groups of NPS are included in generic legislation (this might be problematic because 
various substances of these two groups are widely used as medicines, which makes generic legisla-
tion difficult). A scientific evaluation of the effects of this law will start soon. 
3.3.2 Hungary 
During 2010–2014 new psychoactive substances completely restructured the Hungarian drug market. 
Following the large-scale increase in the amount of mephedrone available in the summer of 2010, the 
proportion of the new psychoactive substances as compared to the classical drugs rose continuously. 
Following mephedrone in 2010, the largest share of cathinones in seizure was 4-MEC and MDPV in 
2011, pentedrone from 2012, and a temporary surge of alpha-PVP in 2014. 
Since autumn 2010 there has also been a continuous rise in the seizures of plant material impregnat-
ed with synthetic cannabinoids. The number of seizures of the products known as ‘herbal’, ’bio weed’ 
or ’sage’ in 2014 was nearly double the number of seizures of herbal cannabis. The range of active 
substances found in the products follow the changes in legislation dynamically, The most frequent 
active substance during 2014 was AB-CHMINACA. 
In Hungary there are no legal ‘offline’ outlets available. NPS is sold illegally primarily on the streets 
(as it is connected to the poorest, low status population), on the countryside they order it from the 
internet and it is shipped by the post. Today there are big dealers (families) in Budapests 8th district 
who buy large quantities from online sources, produce the NPS at home and sell it to users. 
3.3.3 Ireland 
Throughout 2009 and 2010, mephedrone was located in drug scenes within Britain, Northern Ireland 
and the Republic of Ireland, and was obtainable for sale/purchase through numerous sources such as 
dealers, street-based headshops and online vendors. Although there has been closure of all head-
shops in Ireland and products are not openly for sale, it is common knowledge that these are still 
available and accessible on both the black market or on the internet. Available NPS include party pills 
or herbal highs, herbal smoking mixtures or powders such as cathinones. 
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Research shows a post legislation decrease in NPS use; however, legislative controls appear largely 
ineffective in the view of experts. In general experts observed how legislative control and regulation 
has not impacted on how users are sourcing NPS in the Republic who are undeterred by their current 
legal status because of their online and black market availability and successful sourcing over time 
incurring no legal repercussions. 
Recent legislative control in Northern Ireland had a positive impact on cross border NPS drug tourism 
in terms of significantly reducing availability of NPS (most commonly SCBs), but with negative drug 
displacement outcomes in the form of heroin smoking and illicit benzodiazepine trade. 
3.3.4 The Netherlands 
The emergence of NPS in the Netherlands developed in three waves. The first generation of NPS 
appeared in the mid-nineties and consisted largely of fenylethylamines (such as MDEA and 2C-B). 
The second wave was mid noughties and concerned mainly methylone, which was sold in smarts-
hops as Explosion. The third wave, according to the experts, started after the (temporary) ecstasy dip 
2008-2009 with mephedrone (4-MMC) which was available in smartshops and on the internet.  
Currently it is not the poor quality, but precisely the very high purity of ecstasy that makes 4-FA popu-
lar. The milder empathogen 4-FA is seen as an alternative to the high-dosed MDMA. In recent years, 
4-FA supply changed from mainly powder to mainly tablets. 
Virtually all experts (including justice and police) see a clear link to the presence of coffee shops in 
the Netherlands and the varied and accessible range of cannabis that comes with them and the lack 
of enthusiasm to experiment with (potentially risky) synthetic cannabinoid variants. 
3.3.5 Poland 
There is no precise data when the NPS market started its activity in Poland. However, the year 2008 
was a breakthrough in the Polish NPS market with the introduction of the website 
www.dopalacze.com, where users were able to purchase a wide array of NPS. Also in 2008, the first 
smart shop that sold NPS was opened. In a short time (ca. half a year) about 40 retail outlets offering 
the NPS appeared, mainly located in the centres of large towns, and by 2010 almost 1.300 shops 
were a part of the NPS sales network across the country. Almost a year after legislative change, in 
October 2010 the retail outlets offering NPS were closed down based on the decision of the Chief 
Sanitary Inspector who claimed that NPS have negative effects on human health. After the closing of 
stationary shops, NPS business was continued unofficially as ‘under-the-counter’ sales, to the initiat-
ed customers. Currently, NPS can be reached in stores or places whose names do not indicate the 
trade of NPS, for example in sex shops, hot spots and other. 
Access to NPS through online stores is viewed as easy and comfortable. Purchases are often made 
through Darknet. Shopping can be done discreetly, anonymously, quickly. The order is received from 
an anonymous pick-up point (e.g. parcel lockers). According to professionals, clients of online shops 
are mainly those who experiment with various substances, for example hallucinogens. They procure 
larger quantities of the substance, often not only for their own use. 
The Internet purchases are also made by problem drug users as it offers access to a greater variety 
of NPS and lower prices compared to those offered in stationary shops and by private dealers. 
The products offered by stationary and on-line stores mostly comprises of stimulants and herbal mix-
tures, with lesser availability of psychedelics The market is characterized by an instability of products 
offered. Therefore users receive new products about which their knowledge is limited as those previ-
ously tested by them disappear from the market. It is claimed that in some cities NPS have replaced 
conventional drugs on the local markets. 
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3.3.6 Portugal 
The NPS market in Portugal can be divided into two distinct periods of time: before and after the im-
plementation of Decree-Law No. 54/2013 and the closure of all smartshops. According to experts, the 
geographical location of Portugal is one of the major reasons for the easy access and availability of all 
substances in the country. Additional factors appear to influence the autonomous regions of Azores 
and Madeira, making these regions distinct from the rest of Portugal. In these regions availability of 
conventional drugs such as cocaine or heroin is lower and prices are higher. In continental Portugal, 
nearly all NPS can be purchased on the street, but some cases, especially specific substances such 
as salvia or other products which require their own preparations, are mainly purchased online. On the 
autonomous regions substances are also purchased in the street, but they are believed to arrive there 
essentially by post offices, suggesting a greater development of online marketplaces. In the Azores 
there are an additional particularity of migratory flows with Canada and the United States, which 
seems to have a significant influence on new trends, consumption, and availability of substances, 
such as the use of synthetic cannabinoids and cathinones, which seems to be more popular in these 
countries than in Portugal. 
3.4 DEMAND 
3.4.1 Germany 
Most NPS users in night life/party settings are experienced drug users. Experts state that this group of 
users does not have a selective use of substances and that they often use different sources like fami-
ly, friends, or just someone in the club. Socially marginalized NPS users from the problem drug user 
scene are usually long-term users. The clients are so called heavy users, or problematic drug users 
(PDUs), often homeless and with large quantities of pending criminal proceedings. They are people 
who have already stopped a lot of therapies and most of them show patterns of poly drug use with the 
preferred substance being heroin. 
Motives for NPS use are not directly related to the role of legality but it is important that many NPS 
are not detectable in common urine controls. For ‘psychonauts’ aiming for altered states of con-
sciousness through psychoactive drug use, legality does not seem to play a role. They perceive NPS 
as a complementation of what the market offers and who try every substance anyway. They are gen-
erally driven by a scientific curiosity. 
3.4.2 Hungary 
The herbal-user and the crystal-user is distinguished unambiguously as the main two types of NPS 
users by experts. This would suggest a typology based on the substance characteristics but the ty-
pology of users also represents the complexity of multiple substance use patterns. A third category is 
the multiple disadvantageous user. 
The herbal user is a smoker, who can be an intensified/compulsive user and circumstantial-situational 
or social-recreational user as well, but rather the latter. Marginalized (Roma, homeless) persons and 
middle-class teenagers also use herbals but with different motivations. For middle-class teenagers the 
herbal is like marijuana use. Among marginalised users herbal is regarded the less harmful substance 
(in comparison to crystal): to be or to become herbal user is a status-change, a beginning of the road 
of ‘recovery’. 
The crystal user is typically marginalized, injecting, intensified/compulsive user, who will most proba-
bly have serious health problems and would be difficult to get treatment for them. They have halluci-
nations of bugs and worms under their skin. This experience can lead them to a psychotic condition. 
Their compulsive use is leading to risk behaviours, quick physical and psychic deterioration and 
deaths among users. 
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With the multiple disadvantageous users different factors add up: homelessness; dysfunctional fami-
lies; prison; low status; socio-demographic and -economic characteristics. Roma people are often 
mentioned, but it’s not only a Roma-issue. These users are often indifferent, have nothing to lose and 
use NPS because it’s extremely cheap and very easily available. 
Undoubtedly the crucial motives for using NPS on both individual and national level is the low price 
and the easy accessibility. None of the intense or regular users would be motivated to use NPS be-
cause it’s legal, but infrequent users might. 
3.4.3 Ireland 
Experts identify specific groups of NPS users: college students or young people at parties; ‘Chemsex’ 
men who have sex with men (MSM) groups; entrenched persons who inject drugs (PWID) seeking a 
cheap high not undetectable by routine screening; co-morbid individuals with (often) primary mental 
illness and self-medicating of symptoms. Popular NPS include synthetic cannabinoids; psychedelics; 
GHB alternatives; psychedelic hallucinogenic and stimulant party pills containing the 2-C substances 
and cathinone stimulants such as a-PVP and Mephedrone. 
General reasons for use of NPS centred on user curiosity; experimentation; boredom; peer use; social 
influences; for sexual reasons; better effect and value for money; availability in the form of a ‘cheap 
high’ and potency in comparison to conventional drugs. 
3.4.4 The Netherlands 
NPS surfacing on the Dutch market did so with varying market success. Methylone has virtually dis-
appeared, mephedrone never much caught on and the use of and dissociatives remains low. 4-FA, on 
the other hand, is increasing in popularity according to all the experts, and has nested itself as a ‘drug 
of choice’ in the mainstream. This is also evident from the latest study among frequent visitors of par-
ties, festivals and clubs in the ages 15-35 in the Netherlands (Monshouwer et al., 2016). One quarter 
of the respondents in this study had used 4-FA in the past year; a prevalence rate equal to that of 
cocaine and amphetamines. Experts do not think that users were strongly guided by the legal status 
of the drug. 
The use of NPS is primarily limited to recreational user groups in the Netherlands. The street scene is 
apparently unfamiliar with or not interested in NPS and sticks with the classic street drugs (crack co-
caine and heroin) and methadone. 
3.4.5 Poland 
Basically, NPS users can be divided on the rationale of social integration. The group of socially mar-
ginalized users consists mainly of opiate users and IDUs, often unemployed, operating within the 
‘street drug scene’. Members of this group often lack knowledge on consumed substances, even 
those of them who deal drugs. They are a high-risk group due to the high number of daily injections. 
NPS are also popular among clients of substitution treatment because they may use it without a risk 
of being tested and accused of consumption of psychoactive substances strictly prohibited on metha-
done treatment programmes. Among marginalized drug users the most popular NPS are stimulants 
as synthetic cathinones, while synthetic cannabinoids are used by them from time to time. 
Socially integrated users are those who use NPS in a recreational manner; they work or study, use 
illicit substances during weekend parties, mainly cannabis or synthetic cannabis but, also to some 
extent, stimulants. Socially integrated NPS users are often considered as curious experimentators 
looking for relaxation and fun in their spare time. They are characterised by extensive, advanced and 
state-of-the-art knowledge on NPS, including their compounds, function, dosage, effects. They exper-
iment with novel substances to find new unique experiences. Members of this group are also active 
on the internet, where they can share their trip stories genuine, knowledge and experiences. 
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Availability and affordability were emphasised to be the most important feature of NPS popularity in 
general. NPS have displaced traditional drugs because of price but also due to shortages in supply 
and quality of traditional drugs. Also the internet plays an essential role in access to NPS for both 
integrated and marginalized users providing easy, confidential and anonymous access to a vast offer-
ing of products. Psychological motives of NPS use include curiosity, need for new experiences and 
willingness to avoid legal consequences as well as need for sexual stimulation. Psychoactive sub-
stances are not a social taboo any longer, use of NPS is aimed at particular purpose of intoxication, 
without a wider cultural context. 
3.4.6 Portugal 
Distinguishing between intentional and non-intentional consumption is one of the biggest challenges 
for determining who the consumers are and which NPS are the most consumed in Portugal. Accord-
ing to experts, most of NPS users are non-intentional consumers. However, there is an additional 
niche of intentional consumers with a very specific profile. 
Intentional users of NPS are individuals who are looking for particular substances, such as 2C-B 
drugs’ type, Salvia, or MXE. Normally, these intentional consumers have a significant knowledge 
about drugs and seem to be well informed about drug policies and about accurate methodologies of 
consumption. 
However, the majority of NPS users are unintentional consumers. These consumers are regular users 
of drugs in general who were misled somehow. For instance, drug testing services frequently find 
LSD samples contain NBOMe-x instead. On the other hand, in the case of 2C-B, it is becoming trendy 
in recreational settings on its own, and the consumption can be intentional and repeated. 
In Madeira, before the closing of the smartshops there, NPS users were either minors (< 18) or 
around 25 years and most of these individuals were unemployed and with lower levels of education. 
In the Azores, the consumption trend appears to essentially be a novel experience for those within the 
school aged population, but a problem for those who are a part of a therapeutic program or treatment. 
Synthetic cannabinoids, synthetic opioids, and cathinones seem to be the most consumed NPS in the 
region. 
3.5 PREVENTION ACTIVITIES 
3.5.1 Germany 
Apart from prohibiting some (classes of) NPS, there are no supply reduction strategies in Germany. 
Generally, addiction prevention is one of the pillars of the national drug policy. Because of the hetero-
geneous nature of both NPS and the users of NPS, prevention activities and demand reduction are 
hindered. Currently, prevention and harm reduction activities are basically related to safer use organi-
sations, mainly from the field of party drugs prevention in the night life and information websites. 
There are several prevention activities at parties; clubs; festivals; conferences and workshops, where 
different projects offer information at info-desks, answer questions and provide information flyers. 
Some of the projects are more focussed on providing online information, but generally their activities 
are similar. They also provide information at schools or for professionals. 
Since 2012 there is a website that focuses on harm reduction of NPS use by listing the ingredients 
found in NPS (www.legal-high-inhaltsstoffe.de). The website has pages for users, parents or relatives 
of the users and professionals. This website is based on an acceptance oriented approach, providing 
objective information. 
There are no treatment activities specifically aimed at NPS users. There are some indications that in 
certain areas in Germany, NPS users are seeking more treatment than elsewhere. 
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3.5.2 Hungary 
In Hungary there are no special prevention interventions or other activities aimed at supply reduction 
with regards to NPS use. 
There is general prevention at schools, however, due to regulations, in the school year 2013/2014 
only ten programs were available nationwide. None of the general prevention programs are certain of 
their long-term sustainability because of lack of steady funding. Due to a reorganisation of the gov-
ernment body responsible for supporting and overseeing the prevention programmes, it is currently 
unclear how many organisations are still active in prevention, nor how many persons they are able to 
reach. 
There are no harm reduction programmes aimed at NPS users specifically, but there are needle and 
syringe programmes available in Hungary, a total of 31 programs. 
With regard to the present treatment possibilities, there are no specialised treatment programmes 
targeted at the users of individual substance types, instead programmes target the users of all sub-
stance types or addictions or psychiatric problems in general. A majority of individuals entering treat-
ment have done so as an alternative to criminal proceedings (60% in 2014). From the data on drug 
treatment, one can see the influence of NPS, which implied that NPS-users are able to find their way 
to treatment. 
3.5.3 Ireland 
Ireland’s supply reduction took form in the National Drugs Strategy 2009-2016, endeavouring to moni-
tor headshop activities (pre-legislation) and all other businesses concerned with NPS sales (e.g. 
online vendors) with the objective of guaranteeing no illegal actions were undertaken. This strategy 
also ensures that legislative steps are/were taken in respect of NPS legality where it is deemed ap-
propriate and to consistently monitor and review drugs related legislation, specifically in the area of 
NPS, and refer to EU and a wider international experience and best practice (Department of Health, 
2013). Unfortunately demand reduction data such as custom and excise seizure relating to NPS is 
unavailable in Ireland. 
A report by Kelleher et al. (2011) revealed the outcomes of an NPS review from the Irish perspective, 
which included a review of the markets supplying the substances. This review was authorized by the 
National Advisory Committee on Drugs (NACD) in accordance with Action 14 of the National Drugs 
Strategy (interim) 2009–2016. Action 14 stipulates the monitoring of headshops and other sales out-
lets of NPS, under the Misuse of Drugs Act 1977 and the Misuse of Drugs (Amendment) Regulations 
2007. The review was carried out between May and August 2010 by researchers at the Centre for 
Social and Educational Research (CSER) within the School of Social Sciences and Law at Dublin 
Institute of Technology (DIT), and at the School of Chemical and Pharmaceutical Sciences (DIT). This 
report recommended the following prevention strategies: 
- Efforts put in place to observe online monitoring models already in existence; 
- Collaborate more meticulously with UK and other EU countries’ initiatives that are aimed at 
constraining access to NPS; 
- Data collected at hospital level be centralised appropriately in agencies such as the Economic 
and Social Research Institute (ESRI) (which details hospital admissions each year), the 
Health Research Board (HRB), or the National Advisory Committee on Drugs (NACD). This is 
so as to give a clearer, empirical representation of the harm being caused due to NPS thus 
replacing the system (which was present at that time) of reliance on anecdotal reporting; 
- Standard reporting of NPS intoxication to the National Poisons Information Centre; 
- Usage of online social media platforms such as Facebook, to give a much more dynamic stat-
ing of NPS risks. Additionally, placing advertisements there and actively engaging with chat 
room threads; 
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- Specifically targeted interventions towards polydrug substance users; 
- In light of changes in consumption choices and patterns of NPS use due to legislative chang-
es, the report recommended these changes be observed and assessed so as to identify any 
emerging new risks and to respond appropriately; 
- The establishment of a laboratory specifically dedicated to rigorous testing of new and emerg-
ing NPS; 
- Establishment of a reference standards company/body in Ireland that can respond more swift-
ly as new products appear on the NPS market; 
- Continually adopting a pragmatic public health approach to NPS. 
Much harm reduction information in Ireland is based around needle exchange services aimed at re-
ducing harm to injecting drug users and the spread of blood borne viruses (Van Hout and Hearne, 
2015). However, some services have focused on NPS harm reduction. The Anna Liffey Drug Project, 
has distributed a brochure providing harm reduction information on novel psychoactive substances – 
‘legal highs or otherwise’. In 2010, the Health Service Executive (HSE) launched a national drug 
awareness campaign ‘Legal or illegal highs – they’re anything but safe’. This campaign is predomi-
nantly aimed at individuals aged between 15 and 40 years. The campaign consisted of information on 
T-shirts, posters, and wallet cards; relating to the dangers of and harm reduction advice on NPS. The 
campaign also includes an information booklet for parents explaining all aspects of NPS use, legal 
issues, harm reduction advice, and how to deal with someone having a negative reaction to a synthet-
ic substance (Reitox National Focal Point, 2011). 
Information on treatment is extremely limited in Ireland. However, one recent report showed the num-
bers of people seeking treatment for NPS as their primary problem substance in 2013 was minimal 
(Health Research Board, 2015). 
3.5.4 The Netherlands 
Regarding supply reduction, no specific NPS related activities were developed, apart from banning 
some NPS and therefore making their sale more difficult. However, the national organisation of smart 
shops has advised their members not to sell some types of NPS that are legal, such as 4-FA. 
From a supply reduction focus, there is general prevention at schools. This general prevention aims to 
avoid and reduce the demand for drugs, to postpone the first use of drugs and problematic use and, 
in relation to this, to prevent and reduce the risks for the user and the environment of the drug user. 
There is a national project, ‘Night life, alcohol and drugs’, that works on a safe and healthy night life 
circuit. Information to night life visitors is provided through information leaflets and a website, and 
courses for people working in night life are provided. 
There are no harm reduction programmes aimed at NPS users specifically but there are needle and 
syringe programmes. Drug testing is available and there are peer support programmes. Also, there 
are prevention programmes aimed at reducing dropping out of school, homelessness and child 
abuse. NPS users are always able to join these programmes. Peer information programmes also 
tackle the issue of NPS use when they are active in night life. At the time of this study, extra attention 
was given only to 4-FA as a NPS that is used by a relatively large group. Other NPS are not given any 
explicit attention. At night life and festivals, it is obligatory to have first aid workers present, as is 
providing drinking water. 
With regard to the present treatment possibilities, there are no specialised treatment programmes 
targeted at the users of individual substance types, instead programmes target users of all substance 
types or addictions or psychiatric problems in general. The numbers of NPS users in these pro-
grammes are very low. 
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3.5.5 Poland 
Regarding supply reduction, outlets are controlled and checked whether they sell banned substances. 
In 2010 all smartshops and NPS whole sale businesses were closed down. Since then, websites sell-
ing NPS and thematic forums are continuously monitored by government institutions. 
Strategies for reducing demand for NPS are the same as in case of other drugs: general prevention 
activities at schools, media campaigns and treatment. In media campaigns emphasis is placed on the 
users unable to know the ingredients of NPS and therefore the health risks. 
The most common forms of prevention are information campaigns, websites and brochures issued by 
the National Bureau of Drug Prevention. In addition, teachers are educated on NPS risk by the Police 
and the General Sanitary Inspection. This education also extends to prison officers. 
According to the interviewed experts there are no general prevention measures for specific NPS in 
Poland. However, there was one recent social media initiative focussing on the mix of synthetic can-
nabinoids called Mocarz. This drug was the source of alarming reports in the Polish media, leading to 
a YouTube movie featuring the head of the General Sanitary Inspection. However, this video was not 
well received due to its poor quality.. 
There are also harm reduction activities in the nightlife setting, aiming at drug users in need and 
providing information by distributing flyers and talk to party-goers. Harm Reduction volunteers also 
distribute water, condoms and earplugs. Among the users themselves, information about NPS is 
shared through the internet, and according to the experts, this is a common way to inform about risks. 
There are no treatment programmes specifically dedicated to NPS users. 
3.5.6 Portugal 
There is no general prevention, nor treatment programmes specially focused on NPS in Portugal. 
Some prevention programmes include NPS if necessary – according to the experts. 
Even without many scientific data available in the country or public debate about the issue, the inter-
viewed experts seemed to have knowledge about NPS. In Portugal the problem started with smarts-
hops (2007), in April 2013 there were changes in the law and in consequence all the smartshops 
where closed. After that, the NPS prevention is limited to some specific services and professionals 
who work directly with drug issues. 
In Portugal, harm reduction programmes that already exist have included NPS in their intervention. 
For example, harm reduction strategies such as drug and pill testing services in recreational settings; 
breathalyser; syringe exchange; snorting; kits with condoms and information have included NPS. 
Due to the differences between continental Portugal and the autonomous regions, Madeira and 
Azores, especially in terms of drug´s prices (higher in the islands), the work that have been done 
about NPS depends directly on the problems of each region. For that, it is possible to notice some 
additional initiatives among institutions working in those islands, although mostly focused in drug law 
and not in specific intervention projects. 
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4 Survey 
Relative to controlled drugs, the use of NPS is less wide-spread, also in drug using groups. Conse-
quently, large numbers of respondents would have to be contacted for estimating prevalence of NPS 
use and many respondents (those who have not used NPS) would not provide information on patterns 
of use; motives; procurement et cetera. The survey was therefore restricted to NPS users. Eligibility 
criteria for the survey were: (1) recent NPS use (at least once in the past 12 months); (2) resident of 
the participating countries and (3) 18 years or older. 
 
A questionnaire was developed covering all themes of the study, and included items about: 
 Demographic characteristics; 
 Prevalence and patterns of use of some controlled drugs; 
 Prevalence and patterns of NPS use (specific: which ones) + poly drug use; 
 Procuring NPS (buying/getting for free; role of Internet); 
 Types of markets (friends/dealer/shops/internet); 
 Perceptions of NPS prevention (incl. role of legal status). 
 
The questionnaire was developed in English and translated into the other languages in this project. To 
guarantee comparability, translation was done back and forth (from /into English). 
 
A targeted sampling methodology was chosen to reach NPS users in each of the three groups: 
1. Socially marginalised users were recruited face-to-face by trained fieldworkers or care profes-
sionals in the street, at or through care and treatment facilities (e.g. drug services, shelters) 
and through snowball sampling. In most cases, pen-and-paper questionnaires were inter-
viewer-administered; 
2. Users in night life were mainly recruited face-to-face on-site at clubs, raves and festivals. Us-
ers in night life mostly self-completed either a pen-and-paper or online questionnaire to which 
they were referred by a flyer containing a link and an individual code; 
3. Users in online communities were recruited by posting messages on drug-related social me-
dia and internet forums. Users in online communities were only given access to the online 
questionnaire. 
 
The next paragraphs provide a description of the fieldwork efforts conducted to recruit socially mar-
ginalised users, users in night life and online community users in each of the six participating coun-
tries, followed by survey results for these three samples. User profiles of marginalised, night life and 
online community samples will be outlined, as well as user profiles of subgroups of recent users of 
separate NPS categories. Then, patterns of NPS use, procurement of NPS, motives for NPS use and 
side effects and problems experienced by the users are described. The final paragraph discusses the 
users’ view on prevention strategies. 
Main results and similarities and differences between samples are presented in text and graphs. De-
tailed figures can be found in Appendix A. This report offers descriptive data and basic comparisons 
between samples. International papers based on more elaborate analyses of specific themes are 
being prepared. 
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4.1 FIELDWORK 
4.1.1 Socially marginalised users 
4.1.1.1 Germany 
Attempts to recruit respondents from the ‘open’ drug scene in Frankfurt on the Main failed because 
there are very few regular NPS users in the local setting of marginalised users. We already knew this 
from the regular ‘open drug scene survey’ in Frankfurt (Werse et al. 2017) and therefore expected low 
numbers of respondents from Frankfurt. This is why we cooperated with a harm reduction centre in 
the centre of Munich which is a main contact point for users of illicit ‘hard drugs’, to be able to conduct 
at least some face-to-face interviews with socially marginalised users. Munich is the only German city 
known to have a significant prevalence of (injected) ‘bath salts’ (mainly stimulants) among marginal-
ised ‘hard drugs’ users. These efforts were partially successful. 
To ensure the scientific standards of conducting interviews with this special user group, a project 
member of the CDR delivered training in conducting interviews to five student employees recruited by 
a peer prevention project in Munich. These five student employees then conducted the interviews with 
some clients of the harm reduction centre mentioned above. Interviews were interviewer-administered 
with pen-and-paper questionnaires. 
Additionally, following the procedure that was used in the Netherlands, we distributed invitation-flyers 
with codes for group-assignment (a code specifically for socially marginalised respondents in this 
case) in organisations that work with socially marginalised users in Munich and Frankfurt. This har-
vested only a small group of marginalised respondents who filled out the questionnaire on their own 
on the internet. This might be due to the fact that entering the code into the questionnaire was volun-
tary. 
4.1.1.2 Hungary 
The data collection among the marginalised users was initiated on the basis of low threshold/harm 
reduction services active in Budapest. These services provide syringe exchange programmes and/or 
other low threshold services, including drop-in, day-care and/or psychosocial consultation. Apart from 
drugs-related service providers, residential care service for homeless people and a special service for 
pregnant women also assisted us in finding the clients who met the selection criteria. Seven to eight 
service providers helped us in total to get the sufficient number of respondents. We included not just 
those persons who benefited from the above mentioned services but also those who were not in ser-
vice at all. To meet this criteria we used a snow-ball technique. Clients of the given services were 
asked to refer the interviewers to persons who were supposed to use NPS, but did not participate in 
any services. Those who were not in the clientele of the mentioned services were given financial in-
centives (cash 1.000 HUF = 3 EUR). 
Before the actual data collection started some pilot interviews were carried out among this particular 
target group, resulting quite a few critical remarks in relation to the interview format: the respondents 
had difficulty in identifying the active ingredients of the substances they were using and they found it 
difficult to respond to the list of motivations. None of the questions were modified as a consequence 
of the pilot but the interviewers were given detailed instructions as to how to behave if and when the 
respondents had difficulties in answering the questions. The respondents participating in the pilot 
were not included in the database. 
In general to ensure the reliability and validity of the whole data collection process a detailed interview 
guide was drafted and discussed with the interviewers. Nine interviewers (students of our university 
majoring in psychology or in social work and young researchers) did the face-to-face data collection. 
The paper and pencil questionnaires were supposed to be self-administered but in many cases due to 
reading and writing inabilities of the respondents it became interviewer-administered. After the inter-
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views were completed the data obtained were registered in the electronic platform (on-line question-
naire). To avoid duplications the TDI (treatment demand indicator) code of the subjects was taken. 
The constant monitoring of the data collection process ensured the early detection of any duplica-
tions. Due to the fact that financial incentives were given it happened 3 times that the same person 
filled in the questionnaire. The duplications were taken out; their responses are not in the data base. 
4.1.1.3 Ireland 
Recruitment of marginalised users began with a search of all drug services (harm reduction and 
counselling services; addiction clinics; opiate substitution in primary care; local and regional drug task 
forces) in all areas of Ireland. A total of 46 services/key professionals were contacted. All were initially 
contacted with an email providing the full details of the study. One week later a follow up email was 
sent to all who had not responded to the initial email. Following this, services were telephoned or cor-
respondence was entered into via email; whichever suited the service/professional. Efforts to com-
municate ceased on a third non response. 
Thirteen services (addiction clinics, opiate substitution and harm reduction services) initially agreed to 
take part in the study, of which six took surveys and agreed to distribute to NPS clients with support 
from the research team at their service. On receipt of the surveys, however twelve services reported 
that they had not treated clients for NPS use in the past 12 months. One service declined to partici-
pate in the study as they did not allow research be carried out with their clients. The team of two re-
searchers visited the six centres and spent a full working day at each. All surveys were interviewer 
administered using pen and paper versions due to client literacy difficulties. These were then inputted 
the following day by the team. Difficulties were encountered where clients had a history of NPS use 
but had not used in the past 12 months. 
Of note is that most marginalized users the team interviewed/surveyed at these centres had only used 
Spice or Snow Blow once or twice in the last 12 months; however many commented that they were 
regular/dependent users of NPS (mostly Snow Blow) two or more years prior the interview. Currently 
in 2017, it would appear from the above, that the Irish Government’s enactment of targeted legisla-
tion, combined with vigorous enforcement, has significantly impacted on the availability of NPS and 
their use by drug users (both problematic and occasional/ recreational). The sample size obtained in 
Ireland is therefore reflective of this policy and enforcement success. 
4.1.1.4 The Netherlands 
In the Netherlands, the number of socially marginalised drug users has been steadily decreasing for 
many years. There is no ‘open drug scene’. Socially marginalised users constitute an ageing popula-
tion, most of them are in their late 40s, 50s or 60s. They predominantly use opioids and/or crack-
cocaine; a small minority uses intravenously. The vast majority is in contact with one or more types of 
care, low threshold services and harm reduction oriented facilities in particular (substitution programs, 
user rooms, housing, shelters for homeless, as well as with (user) organisations that aim to improve 
the rights and health of users. 
We extensively tried to find socially marginalised users of NPS. Firstly, we contacted the different 
organisations in Amsterdam that are in contact with socially marginalised drug users. None of the 
professionals that work with this group (e.g. social workers, outreach workers), knew of any user that 
used NPS. 
Secondly, at our request, they also asked marginalised drug users in their own network themselves 
whether they had ever used for instance synthetic opioids or other NPS themselves, or maybe knew 
of others users taking NPS. These professionals reported that they had to explain the concept of 
NPS. Subsequently, users commonly were surprised to be asked about the use of such substances: 
why would they use other drugs with methadone readily available (and for a smaller group heroin on 
medical prescription), and good quality ‘base coke’ (crack-cocaine) and heroin at the illegal drugs 
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market? Also, this second strategy did not result in getting into contact with socially marginalised us-
ers of NPS. 
Thirdly, we conducted several weeks of field work in the streets, in parks and other settings where we 
might find socially marginalised users of NPS. We had dozens of informal conversations with margin-
alised users. A few times we were referred to specific places (e.g. remote areas where homeless 
would sleep rough) where we might find people that were said to experiment with NPS. We went to 
these places, had informal conservations, but in the end only one socially marginalised user of NPS 
was found included in the survey by interviewer-administered pen-and-paper questionnaire. 
4.1.1.5 Poland 
The fieldwork was conducted between June and August 2016 in four locations: in Warsaw; Cracow; 
Poznań and in the area of Tri-City (Gdańsk, Gdynia and Sopot). The choice of location was deter-
mined by the greater prevalence of NPS use than in other parts of the country, which offered an op-
portunity to cover the study sample successfully. 
Fieldwork was conducted mainly by streetworkers (N=16) and partyworkers (N=7) from Warsaw; Cra-
cow; Poznań and Tri-City (who also conducted survey in the night life setting). Respondents from 
marginalized samples were recruited in the streets; around the treatment units; inside the treatment 
facilities; in the social welfare facilities; in the shelters and night shelters. Interviews were conducted 
face-to-face with use of paper-and-pencil questionnaire. Respondents filled in the questionnaire by 
themselves, with the assistance of street/party workers. 
4.1.1.6 Portugal 
In Portugal the decriminalization model implemented in 2001 has been changing the drug paradigm of 
drugs in the country. Portugal seems to have less marginalized drug users and most of them never 
used NPS. According to GAT (In Mouraria, Group of Activists for treatment), their use seems to be 
more often related with cocaine and heroin, sometimes some hallucinogenic or other traditional drugs. 
According to fieldwork experience in Portugal, most marginalized drug users have never used NPS. 
However, our data suggests the NPS problem exists predominantly in the autonomous regions: in 
Madeira, where prices for conventional drugs are two or more times higher than continental Portugal 
and the Azores, where the prices are also higher, but because of the effects of migration increasing 
the region’s proximity to trends in Canada and the United States (e.g. some tourists bring new trends 
such as NPS from the US). 
Pen-and-paper questionnaires were used over all data collection in this group of users. 
4.1.2 Users in night life 
4.1.2.1 Germany 
As for the ‘marginalised’ scene, we were aware that also among ‘party drugs’ users in Frankfurt, there 
is a very low prevalence of NPS (Werse et al. 2016). Therefore, the efforts to recruit persons for face-
to-face interviews in Frankfurt were of limited success. Several requests were directed to hosts of 
festivals and clubs, but only one allowed us to conduct field research at their events, while the other 
hosts declined to participate. One of our student assistants conducted four interviewer-administered 
interviews there using the pen-and-paper version of the questionnaire. Additionally, again following 
the procedure that was used in the Netherlands, invitation flyers with codes for group-assignment (the 
group of users in night life, in this case) were distributed among the guests of the same club at sever-
al weekends. In order to reach a considerable sample of users in night life and party settings, we co-
operated with peer prevention projects in Munich (five interviewers, who also conducted interviews 
with marginalised users, see 3.1.1.1) and Leipzig (four interviewers) that provide information about 
drugs, drug use and risk reduction to young drug users in clubs, at festivals and parties. 
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As shown in previous research (Werse, 2016), Munich and the surrounding federal state of Bavaria 
appears to be a ‘hotspot’ of NPS use in Germany. Anecdotal evidence (mainly oral reports from drug 
service professionals) indicated that also in East Germany (including the city of Leipzig), there might 
be a considerable prevalence of NPS among party drugs users. 
As for the group of marginalised respondents (in the case of Munich, where interviewers interviewed 
both groups), a member of the CDR carried out special trainings for conducting scientific interviews 
with members of the party projects, who interviewed users in party settings. 
The members of the party projects additionally distributed flyers on parties, in clubs etc., for encourag-
ing users to participate on the online survey by themselves, again using a voluntary code for group 
assignment. 
4.1.2.2 Hungary 
It was the most difficult and least successful part of our data collection. During July and August in 
Budapest the normal party scenes were not really functional. The big festivals were not in town and in 
order to ensure the comparability we decided to stay with the original idea; consequently we tried to 
have all our interviewees from the capital. As during the first weeks of data collection we were not 
able to find the appropriate venues we distributed flyers among the participants of big festivals. A 
special code was given (POn-line-HU) to these people. After the summer period in September and 
October we tried to establish a supportive relationship with party scene owners as we needed their 
permission for doing the interviews. It was difficult and not too successful as these places wanted to 
avoid to make the impression that there was any drug use in their premises. Finally we managed to 
find a few places (3 clubs) where our interviewers were able to do the interviews and/or distribute the 
flyers mentioned before. The relatively low number of respondents in this category is the conse-
quence of the fact that the partygoers were not aware whether they were using NPS. In order to be 
able to find those respondents who were certain that they used NPS a filter question was used before 
the face-to-face interview was administered or the flyer was given. As a general experience we can 
say that the Hungarian partygoers believe that they are using illegal (classical) substances. 
4.1.2.3 Ireland 
Waterford Institute of Technology’s Research Ethics Committee did not grant the team permission to 
approach night life users both inside nightclubs and on the street outside nightclubs. The team, how-
ever, did receive ethical approval to advertise the survey inside nightclubs as an alternative. 
Subsequently, the team focused on two major cities in Ireland: Dublin and Waterford. The team’s 
Research Assistant initially contacted all the local nightclubs and dance venues in Waterford (n=6) 
and Dublin (n=6) via Facebook. All clubs declined to give access permission with the reason that they 
did not wish to associate drug use/drugs research with their clubs. Subsequently the team attempted 
to recruit Irish night life users and the Irish night life community through Facebook groups and pages 
that are specific to Irish clubs and Irish house/dance music and DJs etc. This route to access proved 
limited in terms of eliciting responses. 
4.1.2.4 The Netherlands 
From the beginning of June until mid-August 2016, researchers and trained interviewers visited night 
life locations or festivals on a total of 11 occasions. Respondents were recruited both at festivals and 
in clubs. The interviewers were students, familiar with night life scenes where NPS were used. Before 
the field work started, they were given a training about the aim of the project and were asked to pilot 
the survey, both to get a better idea of the questions and to see whether our survey worked well in 
practice. During the training, interviewers were also informed of the different types of NPS and were 
given an overview of most well-known NPS in the Netherlands. During field work, respondents re-
ceived a small incentive upon completion of the survey. The incentives varied according to type of 
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setting, and the music at the event that was visited. Examples were water pistols, bubble blowers, 
lighters, glow sticks and lolly pops. Most of the time, respondents could choose from different options. 
Respondents were given the option to fill out the survey immediately on the spot - on paper with or 
without assistance of the interviewer - or to fill it out later online. In the latter case, respondents were 
given a flyer with a unique number. When filling out the questionnaire through the Internet, respond-
ents were obliged to enter this number at the start of the survey. 
Not all clubs or festival organisers wanted to be associated with NPS. Sometimes we were allowed to 
move around freely, in other instances we were allowed to create a booth and had to wait for potential 
respondents to approach us. In two instances we weren’t allowed to enter the festival or club, and we 
worked outside, in the shuttle buses to the festival or in front of the entrance to the club. 
Generally, respondents reacted positively to our questionnaire. They enjoyed talking to the interview-
ers and sometimes telling them about their ‘adventures’ with NPS. At one festival, people were more 
apprehensive and, despite the guarantee of anonymity, more reluctant to participate in the survey 
because of privacy reasons. But in other instances, this was not an issue for potential respondents. 
The most important reason not to participate in our study was because people had never used NPS 
(or, more specifically, did not meet the inclusion criterion of NPS use at least once in the past 12 
months); other times potential respondents did not want to spend time on filling out the questionnaire. 
Most respondents were recruited at two large-scale festivals. 
4.1.2.5 Poland 
Fieldwork among night life users was conducted between June and August 2016 in Warsaw; Cracow; 
Poznań and Tri-City (Gdańsk, Gdynia and Sopot). Fieldworkers were experienced partyworkers, who 
had the ability to establish contacts and conduct surveys in clubs. They are working for non-
governmental organisations on a daily basis and had already participated in several projects aimed at 
harm reduction. Their activities were conducted in night life/entertainment venues, to reach 
event//club-goers. These were the places where party workers often do their duties so the venues’ 
staff have already knew them. This helped them to enter the venues and carry out interviews. Inter-
views were conducted face-to-face with paper-and-pencil questionnaires. Respondents filled in the 
questionnaire by themselves, with the assistance of party workers. 
4.1.2.6 Portugal 
The data collection process for night life users was challenging. Entrance to night clubs and festivals 
usually begins around 2:00 AM or 3:00 AM, and people attending these events often socialize and 
consume alcohol in the hours prior to entry. The agency team searched for respondents at many par-
ty places and festivals (around 20 different places – organized parties or not), but it was difficult to find 
people who would agree to talk for, at least, thirty minutes about their NPS use. 
The concept of NPS does not seem to be very clear for the majority of party goers. Many were entire-
ly unfamiliar with the concept of NPS. Trance parties were the easiest location to find NPS users, 
which makes sense in accordance with previous national studies and these contexts (Calado, 2006). 
Additionally, people involved in this culture were helpful and open with the research team. The night 
life workers, such as the party organizers and technicians working in harm reduction (Check!n project 
and APDES) were all very important key-factors in the fieldwork. The parties in the forest were also 
valuable sources for NPS users. The variations in cultures in different settings for drug use were clear 
among the professionals: at techno par-ties, most attendees discussed MDMA and cocaine, and the 
NPS issue did not seem to be a prominent or familiar issue to users in this setting. However, in trance 
parties - ‘hallucinogenic places’ (Calado, 2006) - it was easier to find NPS users (organized parties or 
not). People from this culture seemed to be the major users of NPS, especially regarding their use of 
psychedelics, such as 2C-B, LSA and other kinds of NPS. 
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We have faced a lot of difficulties in finding NPS users (intentional users). However, 2cb, LSA (some-
times), DMT and 25-I and Xanga (a mix of DMT with mescaline, super trendy, especially after boom 
festival as the festival theme was ‘shamanism’) seemed to be the NPS used more often here. 
Pen-and-paper questionnaires were used over all data collection among this group. 
4.1.3 Online community users 
4.1.3.1 Germany 
Online invitations were spread among various internet sources for drug users. These include mainly 
drug forums (eve-rave.ch/forum); Facebook, Twitter and a drug policy activist website. These activists 
also used their social media accounts for further invitations (homepage and social media of the Ger-
man Hemp Association). Additionally, a social worker from a Frankfurt-based drug service who is the 
administrator of the most popular German NPS prevention website (www.legal-high-inhaltsstoffe.de), 
helped to spread the invitations on his site, on Facebook and on the popular drug forum www.land-
der-traeume.de. 
Since mid-2016, online recruitment got stuck at less than 300 respondents, we decided to approach 
additional resources in order to motivate persons to fill out the survey. Since YouTube is a crucial 
medium for young people nowadays, we approached two persons who regularly submit videos on 
drugs issues in Germany: Simon Ruane, a young self-experimenter, whose videos sometimes reach 
several hundreds of thousand views (‘Open Mind’), mentioned our survey on his Facebook account 
and his blog, and Markus Berger, a psychonaut/drug policy activist (‘Drug Education Agency’ and 
‘Nachtschatten Television’; YouTube views around 10,000) even mentioned the survey in one of his 
videos. These efforts obviously contributed to more than 250 additional filled-out questionnaires. 
4.1.3.2 Hungary 
To gather information from the on-line community was the easiest part of the data collection. The links 
to the web based questionnaire was sent out to the online community as soon as the links became 
public and available (June, 2016). Two platforms were used. One of them (www.daath.hu) is the plat-
form of well educated, experienced substance users who are experiential users and they are rigorous-
ly sharing all the relevant information among themselves, including harm reduction messag-
es/information as well. It is more difficult to describe the characteristics of the other platform 
(www.facebook.com/drogriporter), this platform is the meeting point of persons having an interest in 
drug policy related issues. The 2
nd
 platform became included in the 3
rd
 week of the data collection 
period as there was not sufficient activity detected (low number of questionnaires completed) during 
the first 10 days. parallel to the inclusion of the 2
nd
 platform the motivating message was repeated on 
the 1
st
 platform by the moderator. Both platform moderators eagerly assisted us in finding the target 
persons. 
4.1.3.3 Ireland 
Online recruitment began on international forums www.drugs-forum.com, www.legalhighsforum.com, 
and www.bluelight.org. These forums are considered the ‘leading edge’ Internet forums (Psychonaut 
Web Mapping Project) located on the surface web (Deluca et al., 2012) and were chosen based on 
this. 
Following this a search for Irish drug user forums was carried out. However, this returned no results. A 
search for general online forums was then carried out and www.boards.ie was found to be the only 
Ireland based forum where discussions around drugs were present so this forum was contacted also. 
Recruitment to all forums began with a mail to the moderators of the appropriate forum detailing all 
information relating to the NPS study, which had been written by the P.I. of the project. The first forum 
to respond was Drugs-forum and they refused to permission to recruit there. Bluelight responded and 
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agreed to advertise the study on their forum, but as it is a huge international forum, the PI took over 
this and posted the survey there for all countries. The Legal highs forum did not respond and so the 
moderators/admin was contacted again 1 month later, again with no response. As regards the Irish 
forum boards.ie, they initially declined as the Irish research team had just set up an account with them 
as a new member. However, after some contact with the moderator in the research/survey forum it 
was agreed that the Irish team could post the survey. However when the team attempted to do this, 
the site would not allow the survey to be posted. To post surveys/links to research, the forum rules 
stated that a member must have 150 posts to their name, and as a new member the Irish team did 
not have this. As a result the Irish team were not able to recruit online users with the exception of 
those located on Bluelight. 
Following this, the team ran a search on Facebook for some NPS groups/pages using a combination 
of search terms such as ‘legal highs Ireland’, ‘research chemicals Ireland’, ‘Ireland head shops’ etc. 
They found four such groups and contacted all and requested permission to either join a group, if 
private, and if public asked to advertise the survey. One group (Street Aware) read the Facebook 
message and did not reply, the other 3 groups (‘Legal Highs Game Over’; ‘Legal Highs Your Stories 
and Experiences’ and ‘If They Make Legal Highs in Ireland Illegal’) did not respond to the team’s re-
quest to join the group. On looking through the timeline of these groups, it was obvious there had not 
been much activity since 2010 (which coincided with the enactment of the first legislation outlawing 
the selling of legal highs in Headshops in Ireland). The team’s Research Assistant posted information 
and a link to the survey on her personal Facebook page daily from 27.06.16 to date. This is regularly 
shared by friends also. Facebook member interest in completing the survey was sporadic with a low 
uptake because of the inclusion criteria of 12 month prevalence. 
4.1.3.4 The Netherlands 
The survey was distributed through several international and national drugs forums. In addition to the 
international forums (Bluelight.org and reddit.com), the survey was posted on the following forums in 
the Dutch language: drugsforum.nl, partyflock.nl, jointjedraaien.nl, the internet forum of a smart shop 
and on an internet community related to a national TV programme that focuses on young people, 
lifestyle and drug use (‘Spuiten en slikken’). Especially the latter post, combined with the attention 
paid to the study on their Facebook page, generated the largest number of respondents. The re-
sponse through the international forums was very limited for the Netherlands. 
In the selection of Dutch language forums, only forums where users actively participated in discus-
sions about the use of drugs were selected. Forums where only the growing of cannabis was dis-
cussed, were not selected. Forums with no more than a few hundred users or no recent discussion, 
were not selected either. 
In some cases, the messages were posted by a moderator of the forum, giving the posts more credi-
bility and rapport among the forum users. Some of the moderators first filled out the questionnaire 
themselves and then informed us whether they would post it, thereby screening our study and ques-
tionnaire for any subjects or questions they could not stand by. However, none of them refused to 
give us access or refused to post our message. 
After posting messages, the forums were visited regularly by the research team to follow and engage 
in discussions and to answer any questions that discussants would have. In almost all cases, re-
spondents reacted positively and in a constructive way. Sometimes reactions were posted about how 
this study could lead to the ban of more NPS and were sceptical of our intentions. Often, other forum 
users would respond by saying that more knowledge about NPS could never be a bad thing, leading 
to a more constructive discussion about our study. 
For privacy reasons, the source of the internet respondents was not logged, but based on the dates of 
responses. For the Netherlands the most relevant dates were: 
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8 June 2016: Webmaster posted our call for respondents on drugsforum.nl. Some people reacted to 
the call and posted some remarks, all of them positive. 
13 June 2016: A message was posted on the Reddit forum on drugs. This elicited quite some com-
ments, most of them positive. Some users were curious about the reasons for doing the study. 
30 June 2016: Our message on the paryflock.nl forum about drugs is published. Some reactions fol-
lowed, largely positive. 
7 July 2016: We posted a message on jointjedraaien.nl. The message was viewed quite a lot and 
elicited 23 responses. Most of the reactions were from forum users that didn’t understand why we 
posted the message in this forum. For them, NPS are equivalent to chemical drugs, which are equiva-
lent to negative associations. A lot of the conversation put emphasis on the negative consequences of 
Spice. 
14 July 2016: repeated the message on the partyflock.nl forum, emphasising the types of NPS that 
were most used in the Netherlands so far to increase recognisability. Again, the same type of reac-
tions followed. 
27 July 2016: Spuiten en Slikken posts a message on their website to stimulate persons to participate 
in the survey. The text was written by the programme itself. 
28 July 2016: webpage of Spuiten en Slikken shared on their Facebook page. This initiated such a 
high response that we decided not to actively recruit any new respondents. 
4.1.3.5 Poland 
A total number of 4 web forums and 3 social media fan sites (facebook.com) were contacted via 
email. The first wave of contacting was initiated on 14th June 2016. During the first wave all 3 social 
media fansites and one web forum responded to our request. The information of our survey was post-
ed on-line within two days. The second wave took place three weeks later on 4th July. As a result, the 
information on our survey was posted on one additional web forum. Due to high number of responses, 
the two remaining online forums which didn’t respond to our attempts have not been contacted fur-
ther. However, it should be stressed that none of NPS-specific web forums have responded to our 
request. This can be explained due to criminalization and stigmatization of NPS market and its users. 
All in all, the positive response was received from 2 web forums and all contacted social media fans-
ites. The information on web forums have been embedded which made it highly visible easily ac-
cessed to forum users. Detailed plan of implementation can be found below. 
 
Website Type Characteristic Response/ 
Posting 
Hyperreal.info Web 
forum 
The biggest Polish drug users’ forum covering vast 
spectrum of psychoactive substances, including 
NPS 
Yes/Yes 
Wolnekonopie.pl Web 
forum 
The biggest Polish forum dedicated to cannabis 
use and advocacy, covering issues of both natural 
and synthetic cannabinoids  
Yes/Yes 
Dopalacze.info Web 
forum 
NPS-oriented forum  No/No 
Dopalamy.net Web 
forum 
NPS-oriented forum  No/No 
Studencka Inicjatywa Narkopolityki 
 
Social 
media 
The fan site of Student Drug Policy Initiative sup-
porting the idea of decriminalization of drug use 
Yes/Yes 
Polska Sieć Polityki Narkotykowej  Social The fan site of think-tank Polish Drug Policy Net- Yes/Yes 
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media work advocating the idea of decriminalization of 
drug use 
Fundacja Redukcji Szkód Social 
media 
The fan site of Harm Reduction Foundation sup-
porting and delivering low-threshold and harm 
reduction services for drug users 
Yes/Yes 
4.1.3.6 Portugal 
Data collection process for the online users was essentially done through the questionnaire available 
on the international platform ‘Reddit’ and other Portuguese platforms such as ‘Penso logo sou’, 
‘Check!n’, and ‘VICE Portugal’ – all platforms where drugs are the main subject or are frequently dis-
cussed. Generally, Portuguese people seem to prefer using international platforms. In Portugal, there 
are only two web pages related to drug issues: one on Facebook, held by a harm reduction project 
from the non-governmental organization APDES; and the other, on Facebook and on a website, 
called ‘Penso logo Sou’, a forum where many subjects are discussed, including drug issues. We also 
collaborated with VICE magazine, an online magazine focused on current events and issues in socie-
ty. There is only one platform with a Portuguese side, Azarius, but they declined our request for col-
laboration with the survey. 
4.1.4 Response 
A total of 3,503 respondents were recruited in the data collection phase. Among those, 253 were not 
a resident of either of the six participating countries and were excluded for not meeting eligibility crite-
ria. These respondents mainly entered the survey through the international internet forums used in 
the online community fieldwork, but some also responded to posts on national forums or were found 
during night life fieldwork. Additionally, seven minors (15-17 years) were excluded for not meeting 
eligibility criteria. 
Of the remaining 3,243 respondents, 212 were excluded because they had not used any NPS in the 
past 12 months. They either reported names of non-NPS substances when asked which NPS they 
had used in the past year, or – which was more often the case (189 out of 212) – reported their last 
NPS use was more than 12 months ago. The eligibility criterion of last 12 months NPS use was clear-
ly communicated during recruitment and also checked at the very beginning of the questionnaire. This 
general question of last 12 months NPS was answered in the affirmative by these respondents, but 
when asked about specific categories of NPS later in the questionnaire their answers were negative.
2
 
This reflects the general issue encountered during field work that the concept of NPS is not always 
clear at the consumer level. 
Finally, eight respondents were excluded because of questionable validity, based on their silly, irrele-
vant, incoherent or angry comments on open-ended questions. 
 
The final sample of recent NPS users in this study consists of 3,023 recent NPS users, among which 
the online community sample is the largest (2,110) and the marginalised sample the smallest (266). 
For reasons described in the fieldwork section above, the subsamples of marginalised users from the 
Netherlands and Portugal and night life users from Ireland are very small, with less than 10 respond-
ents. 
 
  
                                                     
2
  Including an ‘other’ category, where respondents could enter their answers when they were not sure to which category 
the substance they had used belonged. 
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 MARGINALISED NIGHT LIFE ONLINE TOTAL 
SAMPLE     
Germany 23 98 542 663 
Hungary 101 15 156 272 
Ireland 48 3 11 62 
The Netherlands 1 189 1,000 1,190 
Poland 86 172 338 596 
Portugal 7 170 63 240 
TOTAL 266 647 2,110 3,023 
4.2 USER PROFILES 
4.2.1 Profiles of marginalised, night life and online community recent NPS users 
4.2.1.1 Background characteristics 
See Table 1 in Appendix A 
In all three samples, most respondents are male (marginalised: 71.7%, night life: 67.9%, online: 
68.0%). The online community sample is the youngest with an average age of 23.6 years and 70.3% 
falling within the 18-24 age group; the night life sample is somewhat older (average 25.7). The mar-
ginalised sample is the oldest (average 33.5) with only 17.4% in the 18-24 age group and 10.0% be-
ing 45 years or older. 
 
Figure 3 Age distribution of recent NPS users 
    
 
A vast majority of the marginalised sample lives in a large town with more than 100.000 inhabitants 
(86.8%) and the night life sample also mainly resides in large towns (68.5%). A sizeable part of the 
online community sample, however, lives in small towns with a population of less than 50.000 
(41.2%). 
 
Figure 4 Residence of recent NPS users 
    
 
Most of the night life and online community samples live either with their parents or family (27.6% and 
44.1%) or in a rent apartment or room (47.1% and 39.6%). Compared to these two samples, re-
spondents in the marginalised sample more often live in homeless accommodations or hostels 
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(32.3%) or reported other living arrangements (12.3%), including living on the streets (sleeping 
rough). 
 
Figure 5 Living arrangement of recent NPS users 
    
 
The night life and internet community samples show high levels of education. Many have so far only 
completed a secondary level education (46.2% and 56.2%), but there are also many that are still 
studying for a higher degree (28.6% and 43.7%). And 37.3% and 28.6% already have a college or 
university diploma. Among the marginalised sample most completed no or just primary education 
(55.2%), only few (3.1%) are students and three quarters are unemployed and/or live on benefits 
(75.7%). 
 
4.2.1.2 Drug use history 
See Table 2 in Appendix A 
Generally, life time drug use is common among the samples of recent NPS users. Nearly all night life 
and online community users have ever used cannabis; life time use of cannabis in the marginalised 
sample is only slightly lower. A majority of all samples of NPS users have had experience with the 
traditional stimulant drugs amphetamines, ecstasy and/or cocaine (marginalised: 66.3–88.7%, night 
life: 71.6–89.7%, online: 51.6–87.1%) and many, if not most have ever used magic mushrooms, lsd, 
ketamine, ghb/gbl and unprescribed upper medicines (marginalised: 28.0–54.9%, night life: 28.7–
57.9%, online: 23.6–44.6%). Notably, life time use of crack cocaine, heroin, methamphetamine and 
unprescribed downer medicines is considerably higher in the marginalised sample (29.6–61.2%) than 
the other two samples (6.4–29.1%). When comparing night life with online community NPS samples, 
the latter often show somewhat lower rates of use. 
 
Figure 6 Life time drug use among recent NPS users 
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Among the marginalised sample almost three quarters have ever used drugs intravenously (74.4%) 
compared to 3.6% of night life and 4.9% of online community sample. 
4.2.2 Use of NPS categories 
Information was gathered on the use of seven categories of NPS: 
 Herbal blends (e.g. ‘Spice’) 
 Synthetic cannabinoids (obtained pure) 
 Branded stimulants (e.g. ‘bath salts’) 
 Stimulants/empathogens/nootropics (obtained pure, e.g. mephedrone, MDPV, a-PVP) 
 Psychedelics (e.g. NBOMe-x, 2C-x) 
 Dissociatives (e.g. methoxetamine) 
 Other 
 
For each of these categories, respondents were asked about their use (life time, last 12 months, last 
30 days, and frequency of use in the last 30 days). If respondents indicated last 12 months use, they 
were asked to name up to three NPS they had used within that category. For herbal blends and 
branded stimulants respondents were also asked to name up to three active ingredients. Except for 
the few examples mentioned with the seven categories above, no lists of known NPS or active ingre-
dients per category were provided. 
When analysing the respondent’s answers, it became clear that this categorisation was not necessari-
ly common among NPS users. Names of NPS were not always entered under their proper categories. 
Also, respondents said they did not know the names or active ingredients of NPS they had used. 
The distinction between the categories of herbal blends and synthetic cannabinoids obtained pure, 
and between the categories of branded stimulants and stimulants/empathogens/nootropics obtained 
pure, is especially fluid. Synthetic cannabinoids are sold pure under their chemical name, but under 
the same name also sold as a brand of herbal blends. Likewise, pure stimulants are sold as bath salts 
under their chemical name. Although this deserves further exploration, the lack of a clear-cut distinc-
tion between users of these two pairs of NPS categories is obvious. Therefore, when describing user 
profiles in the following paragraphs, users of herbal blends and/or synthetic cannabinoids obtained 
pure are aggregated into one subgroup. The same holds for users of branded stimulants and/or 
stimulants/empathogens/nootropics obtained pure. For the sake of readability, these categories will 
be referred to as ‘herbal blends and/or pure synthetic cannabinoids’ and ‘branded and/or pure stimu-
lants’ in the text. 
4.2.2.1 Herbal blends and/or synthetic cannabinoids obtained pure 
See Table 3 and Table 4 in Appendix A 
Life time, last year and last month use of herbal blends and/or pure synthetic cannabinoids is higher 
in the marginalised sample than in the night life and online community sample. Current (last 30 days) 
use is three times higher (33.8% versus 11.4–11.9%). The marginalised sample also shows more 
frequent use, with 54.0% of current users using every day (versus 10.7% and 25.1% of current night 
life and online community users). This translates to 17.9% daily users of herbal blends and/or pure 
synthetic cannabinoids in the marginalised sample, 1.2% among the night life sample and 2.8% 
among the online community sample. 
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Figure 7 Use of herbal blends and/or pure synthetic cannabinoids among recent NPS users 
 
 
The three most named herbal blends in the marginalised sample were Mocarz, Spice and Bonzai 
These brands also occur in the top three of the night life and online community sample. However, 
night life users also mention Czeszący grzebień and with online community users Jamaican is the 
most named brand of herbal blends. Notably, about half of those who said they had used herbal 
blends in the past 12 months, stated that they did not know which herbal blends they had used. 
 
When asked about active ingredients of herbal blends, the vast majority of those who said they had 
used these in the past 12 months failed to name any active ingredient (marginalised: 81.2%, night life: 
86.1%, online community: 83.0%). Another interesting result is that – if active ingredients were named 
– night life and online community users most often named synthetic cannabinoids while marginalised 
users appeared to think that herbal blends contain a variety of dangerous chemical compounds (ace-
tone, rat poison, battery acid). 
 
At least two thirds of respondents who said they had used synthetic cannabinoids did not know which 
they had used (marginalised: 69.8%, night life: 75.0%, online community: 68.6%). Synthetic canna-
binoids of the JWH series (mainly JWH-018) were most often named in the online community sample, 
followed by synthetic cannabinoids of the AM series (mainly AM-2201). Ab-chminaca and ab-fubinaca 
shared third place. In the night life sample, only JWH cannabinoids and baka were mentioned by 
more than two respondents. In the marginalised sample no individual synthetic cannabinoid was 
named by more than two respondents. 
 
Comparing the six countries participating in this study, the use of synthetic cannabinoids and/or herb-
al blends is most prevalent in the Hungarian samples, with 89.7% of recent users of NPS having ever 
used these substances and 42.6% having used in the last 30 days. In contrast, life time use among 
recent NPS users in the Dutch samples is 16.6% and current use 4.2%. 
 
Figure 8 Use of herbal blends and/or pure synthetic cannabinoids among recent NPS users 
 
4.2.2.2 Branded stimulants and/or stimulants/empathogens/nootropics obtained pure 
See Table 5 and Table 6 in Appendix A 
The use of branded and/or pure stimulant NPS is also highest in the marginalised sample, but the 
differences are somewhat smaller compared to herbal blends and/or pure synthetic cannabinoids. In 
current (last 30 days) use the difference between marginalised users (45.5%) and online community 
0%
20%
40%
60%
80%
100%
life time last 12 months last 30 days daily
Marginalised
Night life
Online
0%
20%
40%
60%
80%
100%
life time last 12 months last 30 days
Germany
Hungary
Ireland
Netherlands
Poland
Portugal
40 
 
users (43.3%) is negligible. However, 41.6% of current users in the marginalised sample are daily 
users, compared to only 2.3% of current user in the online community sample. Extrapolated to the 
entire sample, 18.2% of marginalised recent NPS users are daily users of branded and/or pure stimu-
lants, while this is the case for 1.0% of online community users. Prevalence and frequency rates of 
branded and/or pure stimulants are lowest in the night life sample, with 25.0% current use and 0.3% 
daily use. 
 
Figure 9 Use of branded and/or pure stimulants among recent NPS users 
 
 
The lack of distinction between branded stimulants and stimulants obtained pure becomes clear when 
looking at the respondents’ answers to the question which brands of stimulants they used. While in 
the marginalised sample, the top three consists of actual brands (Młot Thora, Kryształ górski, Co-
colino and Funky), the three most named ‘brands’ in the night life and online community samples are 
chemical stimulant names (4-MMC or mephedrone, 3-MMC and 4-CMC). 
 
For as far as recent (past 12 months) users of branded stimulants were able to name active ingredi-
ents: alpha-pvp was most named in the marginalised sample and 4-MMC in the night life and online 
community samples. However, most reported that they did not know the active ingredients of the 
branded stimulants they had used (marginalised: 86.5%, night life 86.6%, online community: 79.4%). 
 
Just as chemical stimulant names were reported when asked for branded stimulants in the online 
community sample, a brand (Snow blow) was often reported when asked for stimulants obtained pure 
in the marginalised sample. Again indicating that there is no clear distinction between branded and 
pure sold stimulants at the consumer level. The top three of stimulants used in the night life and 
online community samples are the same: 4-FA, followed by 4-MMC and 3-MMC. 
 
Prevalence rates of branded and/or pure stimulants are highest among samples of Dutch users. Al-
most every recent NPS user from the Netherlands has ever used branded and/or pure stimulants 
(96.7%) and a majority of 60.8% has used it in the past 30 days. German and Portuguese samples 
show the lowest prevalence rates. 
 
Figure 10 Use of branded and/or pure stimulants among recent NPS users 
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4.2.2.3 Psychedelics 
See Table 7 and Table 8 in Appendix A 
Contrasting the NPS categories in the previous paragraphs, the use of psychedelic NPS is more 
prevalent in the night life and online community samples than in the marginalised sample. Life time 
use is more than twice as high (56.4-51.3% versus 22.2%) and last 30 days use is more than three 
times as high 20.1-17.3% versus 5.6%). Daily use is uncommon within the night life and online com-
munity sample (2.5% and 1.2% of current users; 0.5% and 0.2% of total sample). In the marginalised 
sample, 23.1% of current users consume psychedelic NPS every day. Because of the relatively lim-
ited number of current users within this sample, the rate of daily use in the total sample is only 1.1%. 
 
Figure 11 Use of psychedelics among recent NPS users 
 
 
NBOME’s and 2C-B are among the top three of psychedelic NPS used in all three samples. In addi-
tion to these two substances, Changa was often named in the night life sample and 1p-LSD in the 
online community sample. The marginalised sample is distinguished by a large number of recent us-
ers not knowing which psychedelic they had used (59.5%). 
 
Notably, the use of psychedelic NPS is at least twice as prevalent in the samples from Germany and 
Portugal than the samples from the other four participating countries. In comparison, The Netherlands 
and Poland show intermediate prevalence rates and Hungary and Ireland low prevalence rates. Cur-
rent (last 30 days) use, for instance, is 37.1% and 31.2% in the Portuguese and German samples, 
11.9% and 9.1 in the Dutch and Polish samples and 5.5% and 6.5% in the Hungarian and Irish sam-
ples. 
 
Figure 12 Use of psychedelics among recent NPS users 
 
4.2.2.4 Dissociatives 
See Table 9 and Table 10 in Appendix A 
On the whole, the use of dissociative NPS is relatively limited compared to the other categories of 
NPS. It is also the only category of NPS with similar rates of use in the marginalised, night life and 
online community sample. Only in last 30 days use is there a small difference between the night life 
sample (3.2%) and the other two samples (online community: 5.6%, marginalised: 6.0%). And though 
the marginalised sample has some more frequent users among its current users, the proportion of 
daily users in the total samples does not significantly differ (marginalised: 0.8%, night life: 0.2%, 
online community: 0,3%). 
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Figure 13 Use of dissociatives among recent NPS users 
 
 
MXE is the most used dissociative NPS in all three samples. In the online community sample followed 
by MXP and 3-MeO-PCP. In the night life and marginalised samples, other dissociatives were named 
by only a few respondents. A majority of marginalised recent (past 12 months) users of dissociatives 
could not name a specific substance they had used (81.8%), while in the night life and online commu-
nity sample most did know what they had used (79.1% and 67.4%). 
 
Even though the overall prevalence of dissociative NPS use is relatively low, there are still differences 
between the six participating countries, with Germany showing the highest rates (33.9% life time), 
followed by Hungary (28.3%), Poland (27.9%) and Portugal (21.7%), and at some distance Ireland 
(11.3%) and the Netherlands (10.3%). The Hungarian marginalised NPS users are the only subsam-
ple where the use of dissociatives is more prevalent than that of psychedelics (24.8% versus 12.9% 
life time). 
 
Figure 14 Use of dissociatives among recent NPS users 
 
4.2.2.5 Other NPS 
See Table 11 and Table 12 in Appendix A 
Other NPS, not belonging to the categories described in the previous paragraphs, are mostly used in 
the online community sample. Life time, recent and current use is around three times higher than in 
the night life and marginalised samples. Again, The marginalised sample has more frequent users 
among its current users, but the proportion of daily users in the total marginalised sample (0.8%) does 
not differ from that in the online community sample (1.1%). The night life sample has no daily users of 
other NPS. 
 
Figure 15 Use of other NPS among recent NPS users 
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The names of other NPS most mentioned in the online community and night life samples are that of 
benzodiazepine class substances (Etizolam, Diclazepam and Clonazolam), but around a third of the 
recent users (65.7% and 63.9%) does not know the name of the substance(s) they used. The most 
reported other NPS in the marginalised sample, if any, is an opioid analgesic (Furanylfentanyl). 
 
Despite the fact that the prevalence of other NPS use is highest in the total online community sample, 
Germany shows higher rates of other NPS use than the other countries, mainly because of many 
users in the German marginalised sample. For example, in the German marginalised subsample 
21.7% has used other NPS in the past 30 days, compared to 3.0% in the Hungarian marginalised 
subsample and none in the other countries’ marginalised subsamples. For the total country sample, 
prevalence rates are lowest in Ireland and Portugal. 
 
Figure 16 Use of other NPS among recent NPS users 
 
4.2.3 Profiles of recent users of NPS categories 
4.2.3.1 Background characteristics 
See Table 13 and Table 14 in Appendix A 
Most of the recent users of NPS from each of the five categories are male. Users of branded and/or 
pure stimulants, however, are more often females than users of the other four NPS categories (36.8% 
versus 21.4–29.6%). 
 
Figure 17 Gender of recent NPS users per category 
 
 
Recent users of herbal blends and/or pure synthetic cannabinoids show a slightly higher average age 
than the other groups (25.7 versus 24.1–25.1 years), but in general recent users of all categories of 
NPS are mainly young adults aged 18-24 years. 
Concerning residence, recent users of dissociatives more often reside in large towns and recent users 
of other NPS are relatively often from small towns. For all five categories of NPS applies that most 
recent users live with parents/family or rent an apartment or room. 
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Level of education is highest among recent users of branded and pure stimulants, with 30.1% having 
a college or university degree, and lowest among recent users of herbal blends and/or pure synthetic 
cannabinoids, with 23.0% college/university level and 29.3% having finished primary school at most. 
Compared to other categories, unemployment is relatively high among recent users of herbal blends 
and/or pure synthetic cannabinoids (22.9%). 
 
Figure 18 Employment of recent NPS users per category 
   
   
 
In the previous paragraphs percentages of users within the countries’ samples were presented. When 
looking at it from another perspective (the percentage of the countries’ samples within the user 
group), recent users of herbal blends and/or pure synthetic cannabinoids were often recruited in Ger-
many, Poland and Hungary, while recent users of branded and/or pure stimulants were mainly in the 
Dutch sample. Recent users of psychedelics were relatively often found in Portugal. Because of the 
relatively small numbers of respondents in the Irish samples, Ireland is the smallest proportion of re-
cent users in each category. 
 
Figure 19 Sample origin of recent NPS users per category  
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4.2.3.2 Drug use history 
See Table 15 in Appendix A 
Life time use of most drugs is higher among recent users of dissociatives than among recent users of 
other categories of NPS. Life time use of traditional psychedelic drugs – magic mushrooms and lsd – 
is also high among recent users of psychedelic NPS. A history of intravenous drugs use is relatively 
prevalent among recent users of both herbal blends and/or pure synthetic cannabinoid (19.1%) and 
dissociatives (18.1%). 
 
Figure 20 Drug use history of recent NPS users per category 
 
4.3 PATTERNS OF USE 
See Table 16 in Appendix A 
Information on patterns of use other than prevalence and frequency (location of use, use in company 
of others, mode of administration, and preparation of homemade mixes) was gathered in general and 
not for specific categories of NPS. Results are therefore presented for the total samples of marginal-
ised, night life and online community recent NPS users. 
 
Among night life and online community recent users, NPS are most often used in night life venues, 
followed by the users’ own home or friend’s home and in public spaces like streets, parks, forests, 
beaches, etc. They seldom use NPS in user rooms, residential care and other locations (e.g. in a car, 
public toilets, stairways). For marginalised users, public space is the most common and night life is 
notably less mentioned compared to the other two samples. 
 
Figure 21 Location of use among recent NPS users 
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Most night life and online community users are always in the company of other when consuming NPS 
(66.7% and 57.3%); a minority uses mostly or always alone (4.1% and 11.1%). Marginalised users 
use NPS alone more often; 22.9% mostly or always. 
 
Half of the marginalised users usually injects NPS (51.1%). Among the online community users swal-
lowing is the most common mode of administration. Night life users mainly swallow, smoke or snort 
their NPS. 
 
Figure 22 Mode of administration among recent NPS users 
    
 
 
4.4 PROCUREMENT 
See Table 17 in Appendix A 
Even though a majority of recent users in all three samples purchase NPS themselves, marginalised 
users (88.7%) do this more often than night life and online community users (70.9% and 77.0%). Es-
pecially night life users often (also, multiple methods of obtaining NPS could be reported) get NPS for 
free (48.8%), have friends purchase NPS with their money (24.9%) or put money together with friends 
to make a group-buy (30.4%). Marginalised users relatively often (also) get NPS in exchange for 
something (19.5%). 
 
Figure 23 Obtaining NPS among recent NPS users 
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4.4.1 Purchasing NPS 
See Table 17 in Appendix A 
When recent users themselves purchased NPS, marginalised users most often did this from a private 
dealer (51.5%) or a street dealer (33.5%).
3
 Night life users most often purchased from a friend 
(36.9%), followed by a private dealer (32.1%); online community users on the internet (35.3%) or from 
a friend (34.7%). Purchasing from a club dealer was done least often in all three samples. 
 
Figure 24 Purchasing NPS among recent NPS users 
 
 
Purchasing NPS at a shop was done by 21.8% of marginalised users, 14.2% of night life users and 
9.3% of online community users. When buying at a shop, if at all, marginalised users reported buying 
mostly at a headshop (where substance-related merchandise is sold, but no psychoactive substanc-
es), while night life and online community users reported buying mostly at a smartshop (where legal 
psychoactive substances are sold). In total, 6.9% of marginalised users obtained NPS in a headshop; 
9.2% and 5.3% of night life and online community users respectively obtained NPS in a smartshop. 
 
When purchasing NPS though the internet, recent users from all three samples mainly order from a 
dedicated webshop for NPS. The proportion of marginalised users ordering NPS from these web-
shops is the smallest, but even so 9.8% of marginalised users have done so. Online users most often 
buy from a NPS dedicated webshop (30.4%). Darknet marketplaces were also reported to have been 
used by online community users, but to a much lesser extent (6.8%). 
4.4.2 Getting NPS for free or in exchange for something 
See Table 17 in Appendix A 
Someone sharing their NPS with you is the most common way of getting NPS for free. Among the 
total sample of recent night life users 41.9% obtain NPS this way. Among marginalised users this is 
29.3% and among online community users 18.3%. Getting NPS as a gift, including free samples from 
vendors, is less common. 
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Figure 25 Getting NPS for free among recent NPS users 
 
 
As described above, procuring NPS in exchange for something else is not done often and mostly by 
marginalised users. Among marginalised users NPS are usually exchanged for common goods 
(10.5% of the total sample) but also for other (traditional) drugs (5.3%), other NPS (4.5%), work or 
services (4.1%) or sex (3.0%). When NPS are obtained through exchanging among the night life and 
online community users, it is primarily for other traditional drugs (9.1% and 3.9% of the total respec-
tive sample). 
4.5 MOTIVES 
See Table 18 in Appendix A 
To examine motives for NPS use, an adaptation of the Marijuana Motives Measure (MMM) was in-
cluded in the questionnaire. The original MMM (Simons et al.,1998) is a 25 item questionnaire as-
sessing five motives for using cannabis. Each item has a five-point response option (1 almost nev-
er/never, 2 some of the time, 3 half of the time, 4 most of the time, and 5 almost always/always). The 
five motives are labelled: enhancement, coping, social, conformity and expansion. The MMM was 
later extended with two items, reflecting a sixth motive labelled routine (Benschop et al., 2015). This 
extended version of the MMM was modified to measure motives for NPS use in this study. Two items 
from the conformity factor (‘So that others won't kid me’ and ‘Because my friends pressure me to’) 
were omitted because they showed little to no validity in previous studies (Benschop at al., 2015; 
Chabrol et al.,2005; Zvolensky et al., 2007) and were thought to annoy adult respondents. Six items 
reflecting motives unique for NPS and not covered by the MMM were added. 
Whether or not the factor structure of the MMM can be replicated when used to measure motives for 
NPS use, and whether or not the added items constitute one or more additional motivational factors, 
will be subject to further research to be published in the scientific literature. For this report, all items 
are assumed valid and item scores within the known factors are combined into a factor score. 
 
Within the night life and online samples enhancement, social and expansion motives were most often 
reported. While enhancement was also the most reported among marginalised users, this sample 
clearly differs from the other two because of relatively high scores on coping and routine motives. 
Conformity motives are least important in all samples. 
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Figure 26 Motives for NPS use among recent NPS users 
 
 
Of the additional motives included in the questionnaire all but one apply more to marginalised users 
than night life and online community users. Only scores for ‘Expecting different or new experiences’ 
are higher in the night life and online community sample. This seems in line with higher scores on 
enhancement and/or expansion motives. It is noteworthy that scores on the five other added items are 
higher for online community users than night life users. This might indicate differences or nuances in 
motives for use between these samples that is not captured by the original or extended MMM. 
Noteworthy is also that ‘Alleged legality’ and ‘Non-detectability’ are among the least mentioned indi-
vidual motives for NPS use in all three samples. 
 
Figure 27 Additional motives for NPS use among recent NPS users 
 
4.6 SIDE EFFECTS AND PROBLEMS 
See Table 19 in Appendix A 
Within all three sample, the majority had experienced acute unpleasant side effects after NPS use. 
However, the proportion of users who had experienced these effects was substantially larger in the 
marginalised sample (85.3%) than in the night life and online community samples (58.8% and 51.0%). 
This dichotomy between marginalised users on the one hand and night life and online community 
users on the other hand applies for all of the 13 side effects listed in the questionnaire, with aggres-
sion/violence and paranoia showing the largest gap. When comparing night life users and online 
community users with each other, night life users report more unpleasant effects, especially head and 
stomach aches and dizziness. Increased heart rate or palpitation is the most reported side effect in all 
three samples. 
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Figure 28 Acute unpleasant side effects among recent NPS users 
 
 
Mid- or long-term mental and physical problems are also experienced by the majority of the marginal-
ised sample (70.3%), but not within the night life and online community sample (28.4% and 30.9%). 
The same dichotomy between marginalised users on the one hand and night life and online communi-
ty users on the other hand applies for all problems listed, but while night life users reported more un-
pleasant acute effects than online community users, this is not the case for mid- and long-term prob-
lems. Depression is the most reported problem in the night life and online community sample; in the 
marginalised sample it is dependence symptoms and weight loss. 
 
Figure 29 Mid- or long-term mental and physical problems among recent NPS users 
 
 
Regarding social problems from NPS use, again a dichotomy between the marginalised sample and 
the night life and online community samples appears, with marginalised users experiencing these 
problems trice as often (69.1% versus 22.1% and 22.2%). Especially housing and legal problems are 
reported more often by marginalised users. In experiencing conflicts at school or work, there is little or 
no difference between the marginalised sample and the other two samples. This of course is related 
to the fact that most marginalised users do not go to school and are unemployed. 
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Figure 30 Social problems among recent NPS users 
 
4.7 PREVENTIVE STRATEGIES 
See Table 20 in Appendix A 
An item from the 2014 Flash Eurobarometer Young people and drugs was used to assess the re-
spondents’ opinion about the most effective ways for public authorities to reduce drugs problems (in 
general). Online community users clearly favour making drugs legal (76.0%). This preventive strategy 
is also the most reported one among night life users (58.9%). Information and prevention campaigns 
are the second most reported strategy within these samples. In comparison, marginalised users are 
more confident about treatment and rehabilitation of users, reduction of poverty and unemployment, 
and tough measures against dealers. Tough measures against users is considered least effective by 
all three samples. 
 
Figure 31 Preventive strategies suggested by recent NPS users 
 
 
Respondents were also asked whether or not they thought NPS need particular attention by profes-
sionals, and if so, which groups of professionals can best help. Surprisingly, considering they reported 
treatment and poverty relief as important prevention strategies, most marginalised users do not think 
professional attention to NPS is needed (54.1%). Those who do, consider doctors and social workers 
or drug help the preferred professionals. In all three samples, only a small minority feels special atten-
tion to NPS from lawmakers and police is needed. 
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Figure 32 Special attention by professionals needed according to recent NPS users 
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5 Review 
After completion of the draft of this report, five external reviewers with expertise, knowledge and over-
sight were invited to give feedback on the report and comment on generalisability of the findings to 
other EU countries: 
 
 Alexander Grabenhofer-Eggerth 
Gesundheit Österreich GmbH (Austria) 
 Anja Mihevc 
Professional worker, counsellor/psychotherapist for drug users – Association DrogArt (Slovenia) 
 Jane Mounteney 
Head of public Health Unit – EMCDDA (Portugal) 
 Mireia Ventura / Xoán Carbón 
Drug checking coordinator / NPS consultant – Energy Control-ABD (Spain) 
 Agnese Zile-Veisberga 
Senior Policy Advisor – Sectoral Policy Department, Ministry of the Interior (Latvia) 
 
Feedback given by these five reviewers is summarized below. 
 
Is each of the stated research questions and objectives of the research adequately addressed 
in the report? 
 
All reviewers consider the research questions and objectives adequately addressed. 
One reviewer would have liked the prevention section to have included specific harm reduction 
measures such as how users are measuring their doses or if they are analysing their drugs before 
using a drug checking service. In developing the questionnaire, choices had to be made to omit more 
detailed questions on some topics to limit the (already lengthy) completion time. 
Another reviewer would have liked the subject of internet supply to have been addressed more de-
tailed. Market and supply is one of the topics that will be analysed more thoroughly in a paper that is 
being prepared. 
  
Are there any major errors or gaps in the information presented? 
 
The reviewers identified no major errors or gaps in the information. 
Two reviewers commented on the unequal number of respondents by country and group, but the 
general opinion was that the reasons for this were sufficiently explained. The limitations of the studies 
samples in relation to specific topics will be addressed more thoroughly in various papers that are 
being prepared by the project group. 
One reviewer remarked that the supply and demand sections did not reflect differences between 
countries and suggested to add data from national or cross-national studies for background infor-
mation. Differences in supply and demand between countries is analysed further in a paper that is 
being prepared. The requested background information can be found in the separate country reports. 
Finally, one reviewer did not agree with grouping nootropics and stimulants in the same category. 
There has been a lot of discussion within the project group on the current categories of NPS in the 
questionnaire. Eventually, choices had to be made. 
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To what degree are the findings laid out in this report applicable to European countries in gen-
eral and/or your country specifically? 
 
There was general agreement among the reviewers that this study highlights the variety in all aspects 
of the NPS phenomenon (users, substances, policy, prevention, etc.) across countries. The Spanish 
reviewer states that the findings in this study are in consonance with their own findings. The reviewer 
from Slovenia, however, paints a slightly different picture of the use of synthetic cathinones (mainly 3-
MMC) among very young people and that of synthetic cannabinoids in prisons (because of non-
detectability). Another reviewer also mentions NPS use in prison populations as well as among some 
groups of MSM. Future NPS studies may include these populations. 
One reviewer states that the specifics of NPS use in different European countries should be taken into 
account when drafting overall EU responses or national responses, but that the data included in the 
report is a good evidence for both researchers and policy makers, regardless the country. 
  
What do you perceive as the strengths of this research report and what do you perceive to be 
its weaknesses? 
 
Strengths mentioned by the reviewers include the design and methodology of the study and the 
presentation of findings in the report, the variety that is shown between types of users and across 
countries, and the improvement of knowledge that can be used in the development of NPS research 
and policy responses across Europe. 
Limitations were the aforementioned unequal number of respondents by country and group and the 
possible overlap between night life and online user groups. The latter is addressed in a paper that is 
being prepared, elaborating on the recruitment strategies in this study. 
One reviewer suggested strengthening the report by the inclusion of a literature review. An extensive 
review of the growing body of international literature on NPS was not part of this study. However, 
country-specific literature can be found in the six country reports, and topic-specific literature (e.g. 
harm, motives, prevention, supply, etc.) will be included in various papers that are being prepared. 
 
Do you have any further feedback on the overall document not addressed in the preceding 
sections? 
 
Related comments of two reviewers concern the popularity of specific NPS or lack thereof. One re-
viewer was curious about why a certain NPS becomes popular, while other NPS do not stay on the 
market; the other reviewer was curious as to why there is not one “mega-seller”, at least not one that 
has stayed around. 
One reviewer remarked the absence of sources in the inventory section. The information in this sec-
tion originates from previously published country reports and expert reports from each of the partici-
pating countries, based on desk research and expert interviews. In this final report we have tried to 
summarise these 12 reports (more than 250 pages) as concise as possible. For detailed source in-
formation we refer to the respective reports. 
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Table 1 Background characteristics of marginalised, night life and online community recent NPS 
users 
 
MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
GENDER     
male 71.7% 67.9% 68.0% .457 
female 28.3% 21.1% 32.0%  
AGE      
18-24 years 17.4% 50.1% 70.3% .000 
25-34 years 36.7% 41.7% 23.7%  
35-44 years 35.9% 7.6% 5.1%  
45 years and older 10.0% 0.6% 1.0%  
average (sd) 33.5 (8.7) 25.7 (5.9) 23.6 (5.8) .000 
RESIDENCE     
small town (pop. < 50.000) 6.1% 17.3% 41.2% .000 
medium town (pop. 50.000-100.000) 8.1% 14.0% 17.0%  
large town (pop. > 100.000) 85.8% 68.6% 41.8%  
LIVING ARRANGEMENTS     
own home 6.9% 20.8% 14.5% .000 
rent apartment or room 14.6% 47.1% 39.6%  
parents / family 16.5% 27.6% 44.1%  
friend’s home 9.6% 3.4% 1.1%  
residential care 7.7% 0.6% 0.2%  
homeless accommodation / hostel 32.3% 0.3% 0.2%  
other 12.3% 0.2% 0.4%  
LEVEL OF EDUCATION     
none 7.7% 0.3% 0.6% .000 
primary school 47.5% 16.9% 12.8%  
secondary school 37.9% 45.2% 56.2%  
college / university 5.7% 37.3% 28.5%  
doctor’s degree, PhD, etc. 1.1% 0.3% 1.9%  
EMPLOYMENT     
student 3.1% 28.6% 43.7% .000 
full-time worker 3.5% 39.0% 30.6%  
part-time or casual worker 9.4% 12.0% 11.7%  
self-employed 5.9% 9.3% 5.4%  
unemployed / benefits 75.7% 10.8% 8.1%  
other 2.4% 0.3% 0.5%  
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Table 2 Drug use history of marginalised, night life and online community recent NPS users 
 
MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
DRUG USE HISTORY (LIFE TIME)     
cannabis 89.5% 97.3% 96.1% .000 
amphetamines 88.7% 82.0% 73.3% .000 
ecstasy / mdma 74.6% 89.7% 87.1% .000 
cocaine 66.3% 71.6% 51.6% .000 
crack cocaine 43.9% 13.9% 6.4% .000 
heroin / unprescribed opioids 61.2% 10.8% 13.7% .000 
magic mushrooms 43.0% 57.9% 44.6% .000 
lsd 54.9% 57.9% 35.6% .000 
methamphetamines 56.7% 24.1% 14.3% .000 
ketamine 37.8% 44.7% 29.2% .000 
ghb / gbl 28.0% 28.7% 23.6% .017 
unprescribed prescription upper medi-
cines 
29.6% 29.4% 34.4% .029 
unprescribed prescription downer 
medicines 
62.0% 24.0% 29.1% .000 
intravenous drug use 74.4% 3.6% 4.9% .000 
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Table 3 Use of herbal blends and/or synthetic cannabinoids obtained pure among marginalised, night 
life and online community recent NPS users 
  MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
PREVALENCE     
life time 73.3% 55.8% 46.2% .000 
last 12 months 61.3% 31.7% 29.9% .000 
last 30 days 33.8% 12.1% 11.5% .000 
FREQUENCY (LAST 30 DAYS)
4
     
every day 54.0% 10.7% 25.4% .000 
more than 10 times, but not every day 20.7% 22.7% 25.0%  
6-10 times 6.9% 16.0% 9.1%  
3-5 times 5.7% 22.7% 14.7%  
1-2 times 12.6% 28.0% 25.9%  
TOP 3 HERBAL BLENDS NAMED
5
     
1 Mocarz (8) Spice (18) Jamaican (29)  
2 Spice (6) Mocarz (12) Spice (24)  
3 Bonzai (5) Czeszący grzebień 
(7) 
Bonzai (50)  
does not know which herbal blends 43.9% 50.0% 53.6% .119 
TOP 3 ACTIVE INGREDIENTS OF HERBAL 
BLENDS NAMED
5
 
    
1 Acetone (9) JWH cannabinoid 
series (8) 
JWH cannabinoid 
series (20) 
 
2 Rat poison (6) other names < 3 
respondents 
AM cannabinoid 
series (14) 
 
3 Battery acid (4)  Ab-chminaca (8) 
Ab-fubinaca (8) 
 
does not know which active ingredi-
ents 
81.2% 86.1% 83.5% .505 
TOP 3 SYNTHETIC CANNABINOIDS NAMED
6
     
1 all names < 3 re-
spondents 
JWH cannabinoid 
series (8) 
JWH cannabinoid 
series (34) 
 
2  baka (5) AM cannabinoid 
series (28) 
 
3  other names < 3 
respondents 
Ab-chminaca (17) 
Ab-fubinaca (17) 
 
does not know which synthetic canna-
binoids 
69.8% 75.0% 68.6% .667 
 
  
                                                     
4
 Current (last 30 days) users only. Marginalised n = 90, night life n = 78, online community n = 243. Maximum reported fre-
quency of herbal blends or synthetic cannabinoids obtained pure. 
5
 Named by at least three respondents (number of respondents between brackets). Percentage ‘does not know’ refers to re-
spondents who used herbal blends in the past 12 months (marginalised n = 150, night life n = 162, online community n = 448). 
6
 Named by at least three respondents (number of respondents between brackets). Percentage ‘does not know’ refers to re-
spondents who used synthetic cannabinoids in the past 12 months (marginalised n = 67, night life n = 96, online community n = 
376). 
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Table 4 Use of herbal blends and/or synthetic cannabinoids obtained pure among marginalised, night 
life and online community recent NPS users – per country 
 Germany Hungary Ireland Netherlands Poland Portugal p 
LIFE TIME        
marginalised 78.3% 89.1% 41.7% *(100%) 72.1% *(57.1%) .000 
night life 66.3% 86.7% *(100%) 23.8% 77.9% 59.4% .000 
online community 61.8% 90.4% 63.6% 15.2% 85.8% 77.8% .000 
TOTAL 63.0% 89.7% 48.4% 16.6% 81.5% 64.2% .000 
LAST 12 MONTHS        
marginalised 56.6% 77.2% 31.3% *(0%) 64.0% *(28.6%) .000 
night life 35.7% 86.7% *(0%) 13.2% 60.5% 16.5% .000 
online community 42.8% 62.8% 18.2% 9.3% 50.3% 55.6% .000 
TOTAL 42.2% 69.5% 27.4% 9.9% 55.2% 27.1% .000 
LAST 30 DAYS        
marginalised 0% 65.3% 6.3% *(0%) 22.1% *(28.6%) .000 
night life 12.2% 46.7% *(0%) 5.8% 20.9% 7.1% .000 
online community 15.5% 27.6% 9.1% 3.9% 16.3% 33.3% .000 
TOTAL 14.5% 42.6% 6.5% 4.2% 18.5% 14.6% .000 
* excluded from comparative analysis because of small group size (< 10 respondents)  
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Table 5 Use of branded stimulants and/or stimulants/empathogenics/nootropics obtained pure 
among marginalised, night life and online community recent NPS users 
  MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
PREVALENCE     
life time 85.0% 73.1% 79.9% .000 
last 12 months 76.7% 57.3% 72.8% .000 
last 30 days 45.5% 25.0% 43.3% .000 
FREQUENCY (LAST 30 DAYS)
 7
     
every day 41.6% 1.3% 2.3% .000 
more than 10 times, but not every day 26.5% 5.9% 8.0%  
6-10 times 16.8% 9.2% 7.9%  
3-5 times 4.4% 24.8% 20.6%  
1-2 times 10.6% 58.8% 61.3%  
TOP 3 BRANDED STIMULANTS NAMED
8
     
1 Młot Thora (16) Cocolino (14) 4-MMC (16)  
2 Kryształ górski (14) Funky (3) 3-MMC (12)  
3 Cocolino (6) other names < 3 
respondents 
4-CMC (10)  
does not know which branded stimu-
lants 
25.4% 53.7% 62.7% .000 
TOP 3 ACTIVE INGREDIENTS OF BRANDED 
STIMULANTS NAMED
8
 
    
1 Alpha-pvp (4) 4-MMC (4) 4-MMC (14)  
2 MDVP (4) Alpha-pvp (3) 3-MMC (13)  
3 other names < 3 
respondents 
other names < 3 
respondents 
4-CMC (9)  
does not know which active ingredi-
ents 
86.5% 86.6% 79.4% .154 
TOP 3 STIMU-
LANTS/EMPATHOGENICS/NOOTROPICS 
NAMED
9
 
    
1 Snow blow (25) 4-FA (123) 4-FA (622)  
2 4-MMC (24) 4-MMC (109) 4-MMC (92)  
3 Alpha-pvp (10) 
MDVP (10) 
3-MMC (30) 3-MMC (66)  
does not know which stimu-
lants/empathogenics/nootropics 
48.9% 26.8% 39.8% .000 
 
  
                                                     
7
 Current (last 30 days) users only. Marginalised n = 121, night life n = 162, online community n = 914. Maximum reported 
frequency of branded stimulants or stimulants/empathogenics/nootropics obtained pure. 
8
 Named by at least three respondents (number of respondents between brackets). Percentage ‘does not know’ refers to re-
spondents who used branded stimulants in the past 12 months (marginalised n = 127, night life n = 69, online community n = 
234). 
9
 Named by at least three respondents (number of respondents between brackets). Percentage ‘does not know’ refers to re-
spondents who used stimulants/empathogenics/nootropics obtained pure in the past 12 months (marginalised n = 147, night life 
n = 350, online community n = 1.477). 
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Table 6 Use of branded stimulants and/or stimulants/empathogenics/nootropics obtained pure 
among marginalised, night life and online community recent NPS users – per country 
 Germany Hungary Ireland Netherlands Poland Portugal p 
LIFE TIME        
marginalised 87.0% 86.1% 93.8% *(100%) 77.9% *(85.7%) .094 
night life 58.2% 26.7% *(100%) 95.2% 80.8% 52.9% .000 
online community 47.0% 80.1% 63.6% 97.0% 85.2% 65.1% .000 
TOTAL 50.1% 79.4% 88.7% 96.7% 82.9% 57.1% .000 
LAST 12 MONTHS        
marginalised 78.3% 81.2% 81.3% *(100%) 67.4% *(85.7%) .123 
night life 39.8% 13.3% *(100%) 92.6% 73.8% 14.7% .000 
online community 37.1% 60.9% 27.3% 96.1% 74.6% 39.7% .000 
TOTAL 38.9% 65.8% 72.6% 95.5% 73.3% 23.3% .000 
LAST 30 DAYS        
marginalised 65.2% 60.4% 18.8% *(0%) 39.5% *(28.6%) .000 
night life 14.3% 0% *(0%) 48.1% 28.5% 4.7% .000 
online community 19.2% 21.8% 9.1% 63.2% 39.1% 17.5% .000 
TOTAL 20.1% 34.9% 16.1% 60.8% 36.1% 8.8% .000 
* excluded from comparative analysis because of small group size (< 10 respondents)  
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Table 7 Use of psychedelics among marginalised, night life and online community recent NPS users 
  MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
PREVALENCE     
life time 22.2% 56.4% 51.3% .000 
last 12 months 14.7% 48.5% 41.7% .000 
last 30 days 5.6% 20.1% 17.3% .000 
FREQUENCY (LAST 30 DAYS)
 10
     
every day 23.1% 2.5% 1.2% .000 
more than 10 times, but not every day 7.7% 4.3% 1.2%  
6-10 times 15.4% 11.1% 3.9%  
3-5 times 30.8% 34.2% 18.1%  
1-2 times 23.1% 47.9% 75.5%  
TOP 3 PSYCHEDELICS NAMED
11
     
1 NBOMe (6) 2C-B (191) 2C-B (351)  
2 2C-B (4) NBOMe (70) 1p-LSD (168)  
3 Młot Thora (3) Changa (37) NBOMe (123)  
does not know which psychedelics 59.5% 14.8% 18.3% .000 
 
Table 8 Use of psychedelics among marginalised, night life and online community recent NPS users – 
per country 
 Germany Hungary Ireland Netherlands Poland Portugal p 
LIFE TIME        
marginalised 73.9% 12.9% 8.3% *(100%) 25.6% *(28.6%) .000 
night life 82.7% 0% *(33.3%) 48.1% 20.3% 93.5% .000 
online community 74.7% 37.2% 72.7% 38.4% 54.1% 71.4% .000 
TOTAL 75.9% 26.1% 21.0% 40.0% 40.3% 85.8% .000 
LAST 12 MONTHS        
marginalised 43.5% 7.9% 4.2% *(100%) 18.6% *(28.6%) .000 
night life 69.4% 0% *(0%) 40.2% 9.9% 90.0% .000 
online community 64.9% 24.4% 36.4% 32.5% 37.0% 55.6% .000 
TOTAL 64.9% 16.9% 9.7% 33.8% 26.5% 79.2% .000 
LAST 30 DAYS        
marginalised 13.0% 5.9% 0% *(0%) 4.7% *(28.6%) .120 
night life 28.6% 0% *(0%) 11.6% 3.5% 43.5% .000 
online community 32.5% 5.8% 36.4% 12.0% 13.0% 20.6% .000 
TOTAL 31.2% 5.5% 6.5% 11.9% 9.1% 37.1% .000 
* excluded from comparative analysis because of small group size (< 10 respondents)  
                                                     
10
 Current (last 30 days) users only. Marginalised n = 15, night life n = 130, online community n = 366. 
11
 Named by at least three respondents (number of respondents between brackets). Percentage ‘does not know’ refers to 
respondents who used psychedelics in the past 12 months (marginalised n = 39, night life n = 314, online community n = 879). 
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Table 9 Use of dissociatives among marginalised, night life and online community recent NPS users 
  MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
PREVALENCE     
life time 22.6% 21.6% 21.3% .896 
last 12 months 13.9% 14.4% 13.6% .867 
last 30 days 6.0% 3.2% 5.6% .048 
FREQUENCY (LAST 30 DAYS)
 12
     
every day 18.2% 5.6% 6.0% .014 
more than 10 times, but not every day 18.2% 0% 4.0%  
6-10 times 18.2% 0% 8.0%  
3-5 times 27.3% 44.4% 23.0%  
1-2 times 18.2% 50.0% 59.0%  
TOP FIVE DISSOCIATIVES NAMED
13
     
1 MXE (5) MXE (85) MXE (107)  
2 other names < 3 
respondents 
DXE (6) MXP (40)  
3  3-MeO-PCP (3) 
3-MeO-PCE (3) 
MXP (3) 
3-MeO-PCP (36)  
does not know which dissociatives 81.8% 20.9% 32.6% .000 
 
Table 10 Use of dissociatives among marginalised, night life and online community recent NPS users – 
per country 
 Germany Hungary Ireland Netherlands Poland Portugal p 
LIFE TIME        
marginalised 69.6% 24.8% 6.3% *(100%) 16.3% *(14.3%) .000 
night life 51.0% 0% *(0%) 16.9% 9.9% 24.1% .000 
online community 29.3% 33.3% 36.4% 9.0% 39.9% 15.9% .000 
TOTAL 33.9% 28.3% 11.3% 10.3% 27.9% 21.7% .000 
LAST 12 MONTHS        
marginalised 30.4% 17.8% 2.1% *(100%) 11.6% *(0%) .006 
night life 34.7% 0% *(0%) 13.2% 2.9% 17.1% .000 
online community 20.3% 13.5% 18.2% 6.8% 23.1% 11.1% .000 
TOTAL 22.8% 14.3% 4.8% 7.9% 15.6% 15.0% .000 
LAST 30 DAYS        
marginalised 8.7% 11.9% 0% *(0%) 2.3% *(0%) .010 
night life 5.1% 0% *(0%) 3.2% 1.2% 4.7% .266 
online community 9.4% 4.5% 9.1% 2.7% 9.2% 1.6% .000 
TOTAL 8.7% 7.0% 1.6% 2.8% 5.9% 3.8% .000 
* excluded from comparative analysis because of small group size (< 10 respondents)  
                                                     
12
 Current (last 30 days) users only. Marginalised n = 16, night life n = 21, online community n = 118. 
13
 Named by at least three respondents (number of respondents between brackets). Percentage ‘does not know’ refers to 
respondents who used dissociatives in the past 12 months (marginalised n = 37, night life n = 93, online community n = 286). 
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Table 11 Use of other NPS among marginalised, night life and online community recent NPS users 
  MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
PREVALENCE     
life time 10.9% 13.0% 34.3% .000 
last 12 months 6.0% 8.2% 26.3% .000 
last 30 days 3.0% 4.5% 15.6% .000 
FREQUENCY (LAST 30 DAYS)
 14
     
every day 25.0% 0% 7.7% .014 
more than 10 times, but not every day 50.0% 8.3% 11.3%  
6-10 times 0% 16.7% 7.7%  
3-5 times 0% 25.0% 17.0%  
1-2 times 25.0% 50.0% 55.1%  
TOP 3 OTHER NPS NAMED
15
     
1 Furanylfentanyl (6) Clonazolam (3) Etizolam (34)  
2 other names < 3 
respondents 
other names < 3 
respondents 
Diclazepam (19)  
3   Clonazolam (18)  
does not know which other NPS 40.0% 63.9% 65.7% .029 
 
Table 12 Use of other NPS among marginalised, night life and online community recent NPS users – 
per country 
 Germany Hungary Ireland Netherlands Poland Portugal p 
LIFE TIME        
marginalised 69.6% 5.0% 6.3% *(0%) 4.7% *(14.3%) .000 
night life 24.5% 0% *(33.3%) 12.7% 8.1% 12.4% .002 
online community 38.6% 53.8% 63.6% 23.5% 48.2% 39.7% .000 
TOTAL 37.6% 32.7% 17.7% 21.8% 30.4% 19.6% .000 
LAST 12 MONTHS        
marginalised 43.5% 4.0% 0% *(0%) 1.2% *(14.3%) .000 
night life 19.4% 0% *(0%) 9.0% 4.7% 5.3% .000 
online community 29.5% 36.5% 45.5% 21.0% 30.8% 28.6% .000 
TOTAL 28.5% 22.4% 8.1% 19.1% 19.0% 11.7% .000 
LAST 30 DAYS        
marginalised 21.7% 3.0% 0% *(0%) 0% *(0%) .000 
night life 9.2% 0% *(0%) 5.8% 2.3% 2.9% .078 
online community 16.1% 17.9% 36.4% 13.9% 17.2% 20.6% .137 
TOTAL 15.2% 11.4% 6.5% 12.6% 10.4% 7.5% .011 
* excluded from comparative analysis because of small group size (< 10 respondents)  
                                                     
14
 Current (last 30 days) users only. Marginalised n = 8, night life n = 29, online community n = 329. 
15
 Named by at least three respondents (number of respondents between brackets). Percentage ‘does not know’ refers to 
respondents who used other NPS in the past 12 months (marginalised n = 16, night life n = 53, online community n = 554). 
Table 13 Background characteristics of recent (last 12 months) users of NPS categories 
 
HERBAL BLENDS 
AND/OR PURE SYN-
THETIC CANNA-
BINOIDS 
n = 998 
 
 
BRANDED AND/OR 
PURE STIMULANTS 
n = 2.112 
 
 
 
PSYCHEDELICS 
n = 1.232 
 
 
 
DISSOCIATIVES 
n = 416 
 
 
 
OTHER NPS 
n = 629 
SAMPLE      
Germany 28.1% 12.2% 34.9% 36.3% 30.3% 
Hungary 18.9% 8.5% 3.7% 9.4% 9.8% 
Ireland 1.7% 2.1% 0.5% 0.7% 0.8% 
The Netherlands 11.8% 53.8% 32.6% 22.6% 36.4% 
Poland 33.0% 20.7% 12.8% 22.4% 18.1% 
Portugal 6.5% 2.7% 15.4% 8.7% 4.5% 
GENDER      
male 76.5% 63.2% 75.9% 78.6% 70.4% 
female 23.5% 36.8% 24.1% 21.4% 29.6% 
AGE       
18-24 years 57.8% 62.9% 62.5% 60.6% 66.1% 
25-34 years 28.6% 27.4% 29.5% 29.7% 26.8% 
35-44 years 10.9% 8.1% 7.1% 8.5% 6.2% 
45 years and older 2.7% 1.5% 0.8% 1.2% 1.0% 
average (sd) 25.7 (7.6) 24.7 (6.6) 24.6 (6.2) 25.1 (6.5) 24.1 (6.1) 
RESIDENCE      
small town (pop. < 50.000) 34.6% 31.1% 32.0% 26.7% 36.5% 
medium town (pop. 50.000-100.000) 13.9% 15.4% 15.1% 16.4% 17.0% 
large town (pop. > 100.000) 51.5% 53.5% 52.9% 56.9% 46.4% 
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Table 14 Background characteristics of recent (last 12 months) users of NPS categories - continued 
 
HERBAL BLENDS 
AND/OR PURE SYN-
THETIC CANNA-
BINOIDS 
n = 998 
 
 
BRANDED AND/OR 
PURE STIMULANTS 
n = 2.112 
 
 
 
PSYCHEDELICS 
n = 1.232 
 
 
 
DISSOCIATIVES 
n = 416 
 
 
 
OTHER NPS 
n = 629 
LIVING ARRANGEMENTS      
own home 13.0% 15.0% 13.7% 13.2% 14.4% 
rent apartment or room 32.1% 38.6% 45.3% 42.3% 40.1% 
parents / family 40.8% 38.4% 36.5% 34.5% 40.7% 
friend’s home 3.5% 2.3% 1.6% 4.4% 2.3% 
residential care 2.3% 0.8% 0.5% 0.7% 0.7% 
homeless accommodation / hostel 5.5% 3.4% 1.2% 2.7% 0.8% 
other 2.8% 1.6% 1.2% 2.2% 1.0% 
LEVEL OF EDUCATION      
none 2.4% 1.1% 0.7% 1.4% 0.7% 
primary school 26.9% 12.5% 16.5% 22.7% 17.9% 
secondary school 45.8% 55.0% 53.7% 49.3% 53.3% 
college / university 23.0% 30.1% 27.9% 25.6% 26.1% 
doctor’s degree, PhD, etc. 1.8% 1.3% 1.2% 1.0% 2.1% 
EMPLOYMENT      
student 26.2% 40.7% 37,5% 32.4% 39.1% 
full-time worker 27.3% 28.4% 31.7% 30.5% 29.4% 
part-time or casual worker 14.4% 11.1% 10.4% 11.5% 12.4% 
self-employed 7.7% 5.5% 7.8% 6.1% 6.7% 
unemployed / benefits 22.9% 13.8% 12.0% 18.3% 11.3% 
other 1.4% 0.6% 0.6% 1.2% 1.1% 
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Table 15 Drug use history of recent (last 12 months) users of NPS categories 
 
HERBAL BLENDS 
AND/OR PURE SYN-
THETIC CANNA-
BINOIDS 
n = 998 
 
 
BRANDED AND/OR 
PURE STIMULANTS 
n = 2.112 
 
 
 
PSYCHEDELICS 
n = 1.232 
 
 
 
DISSOCIATIVES 
n = 416 
 
 
 
OTHER NPS 
n = 629 
DRUG USE HISTORY (LIFE TIME)      
cannabis 98.0% 94.8% 97.5% 97.8% 96.4% 
amphetamines 80.1% 77.3% 83.4% 92.8% 84.6% 
ecstasy / mdma 76.7% 90.0% 92.2% 91.1% 88.8% 
cocaine 52.3% 58.8% 64.4% 69.2% 62.1% 
crack cocaine 14.0% 10.8% 12.2% 19.6% 11.9% 
heroin / unprescribed opioids 24.4% 17.7% 20.8% 35.7% 24.5% 
magic mushrooms 52.9% 40.4% 65.2% 72.3% 56.1% 
lsd 48.9% 33.6% 63.8% 73.3% 50.2% 
methamphetamines 31.5% 21.3% 20.2% 36.9% 25.6% 
ketamine 28.5% 34.0% 48.1% 62.7% 42.4% 
ghb / gbl 26.9% 28.4% 31.2% 42.6% 34.9% 
unprescribed prescription upper medicines 34.8% 35.1% 42.6% 51.0% 47.4% 
unprescribed prescription downer medicines 39.3% 30.9% 37.9% 58.2% 45.3% 
intravenous drug use 19.1% 13.0% 7.5% 18.1% 9.8% 
 
Table 16 Patterns of NPS use among marginalised, night life and online community recent NPS users 
 
MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
WHERE     
own home 39.8% 44.0% 49.2% .003 
friend’s home 30.5% 52.2% 46.1% .000 
night life 16.9% 83.3% 71.2% .000 
work or school 7.1% 8.3% 7.5% .734 
street, park, etc. 64.3% 28.6% 22.4% .000 
user rooms / low-threshold services 6.4% 0.6% 0.6% .000 
residential care / hostel 10.5% 1.5% 1.0% .000 
other 5.6% 1.1% 1.8% .000 
WITH WHOM     
always alone 7.9% 0.8% 2.0% .000 
mostly alone 15.0% 3.3% 9.1%  
equally often alone and in company 26.7% 8.0% 13.7%  
mostly in company 28.2% 22.2% 17.7%  
always in company 21.1% 65.7% 57.3%  
other 1.1% 0% 0.2%  
MODE OF ADMINISTRATION     
smoking 29.7% 25.6% 19.0% .000 
vaporising 3.4% 0.2% 1.6%  
Snorting 11.3% 27.8% 16.2%  
swallowing 2.6% 45.6% 61.6%  
injecting 51.1% 0.8% 0.8%  
anal / rectal insertion 0% 0% 0.4%  
eyeball insertion 0% 0% 0%  
other 1.9% 0% 0.5%  
HOMEMADE PREPARATION     
no homemade preparation 81.2% 89.0% 84.3% .002 
homemade mix with herbs 4.1% 2.5% 4.6% .058 
homemade mix with tobacco 5.3% 5.3% 5.5% .977 
homemade e-liquid 1.1% 0.6% 1.7% .113 
homemade mix with various NPS 3.8% 3.1% 3.8% .703 
homemade mix with traditional drugs 4.9% 1.9% 4.4% .010 
other 0.8% 1.1% 1.6% .382 
MIXED USE*
16
     
mixed with other NPS 2.3 (1.6) 2.0 (1.5) 2.1 (1.5) .085 
mixed with traditional use 2.3 (1.6) 3.1 (1.5) 3.1 (1.6) .000 
mixed with alcohol 2.4 (1.5) 3.2 (1.4) 2.9 (1.5) .000 
 
 
  
                                                     
16
 Average score of 5-point scale never (1) to always (5). 
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Table 17 Procurement of NPS among marginalised, night life and online community recent NPS users 
 
MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
OBTAINING NPS     
purchased / bought 88.7% 70.9% 77.0% .000 
got it for free 35.0% 48.8% 23.2% .000 
in exchange for something 19.5% 12.4% 6.2% .000 
friend purchased it with my money 15.0% 24.9% 20.5% .003 
group-buy 22.2% 30.4% 20.7% .000 
other 10.1% 0.8% 1.4% .471 
PURCHASING NPS     
at a shop 21.8% 12.4% 9.3% .000 
on the internet 12.0% 20.7% 35.3% .000 
from a private dealer 51.5% 32.1% 16.9% .000 
from a club dealer 3.8% 9.1% 4.0% .000 
from a street dealers 33.5% 8.7% 7.1% .000 
from a friend 15.8% 36.9% 34.7% .000 
other 0% 0.3% 0.5% .565 
n/a (did not purchase) 11.3% 29.1% 23.0% .000 
PURCHASING NPS AT A SHOP     
headshop 6.9% 1.2% 1.7% 
17
… 
smartshop 5.0% 9.2% 5.3%  
sexshop 1.9% 1.4% 0.2%  
kiosk 0.8% 0.2% 0.4%  
casino 3.4% 0% 0.2%  
other 2.3% 0% 0.4%  
n/a (did not purchase at a shop) 79.9% 88.0% 91.8%  
PURCHASING NPS ON THE INTERNET     
dedicated shop for NPS 9.8% 14.4% 30.4% .000 
internet forum 2.3% 5.1% 3.4% .054 
social media 1.5% 2.2% 0.9% .035 
darknet marketplace 1.1% 3.2% 6.8% .000 
darknet vendor without marketplace 1.1% 1.5% 2.2% .319 
other 0% 1.1% 0.8% .245 
n/a (did not purchase on the internet) 88.0% 79.3% 64.7% .000 
GETTING NPS FOR FREE     
got is as a gift 15.0% 16.2% 10.5% .000 
someone shared with me 29.3% 41.9% 18.3% .000 
other 0.8% 0.2% 0.4% .387 
n/a (did not get for free) 65.0% 51.2% 76.8% .000 
EXCHANGING NPS FOR SOMETHING     
other (traditional) drugs 5.3% 9.1% 3.9% .000 
other NPS 4.5% 3.4% 2.5% .105 
common goods 10.5% 3.1% 1.7% .000 
work / service 4.1% 1.7% 0.7% .000 
sex 3.0% 0.3% 0.3% .000 
other 0.4% 0.2% 0% .123 
n/a (did not exchange) 80.5% 87.6% 93.8% .000 
 
 
  
                                                     
17
 Statistic cannot be computed because of low counts. 
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Table 18 Motives for NPS use among marginalised, night life and online community recent NPS users 
 
MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
COPING     
To forget my worries 3.1 (1,5) 1.7 (1.1) 1.5 (1.0) .000 
To forget about my problems 3.3 (1.5) 1.6 (1.1) 1.5 (1.0) .000 
Because it helps me when I feel de-
pressed or nervous 
3.2 (1.5) 1.7 (1.1) 1.6 (1.2) .000 
To cheer me up when I am in a bad 
mood 
3.2 (1.5) 1.8 (1.1) 1.6 (1.0) .000 
TOTAL 3.2 (1.2) 1.7 (1.0) 1.6 (0.9) .000 
ENHANCEMENT     
Because it gives me a pleasant feeling 3.6 (1.4) 4.0 (1.3) 4.2 (1.2) .000 
Because I like the feeling 3.7 (1.4) 3.9 (1.3) 4.1 (1.3) .000 
Because it's fun 2.7 (1.5) 4.1 (1.2) 4.1 (1.3) .000 
To get high 3.2 (1.7) 3.0 (1.7) 3.0 (1.6) .281 
Because it’s exciting 2.6 (1.5) 3.3 (1.5) 2.8 (1.5) .000 
TOTAL 3.2 (1.0) 3.7 (1.0) 3.7 (0.9) .000 
SOCIAL     
Because it makes social gatherings 
more fun 
1.9 (1.3) 2.8 (1.4) 2.4 (1.4) .000 
Because it helps me enjoy a party 2.1 (1.5) 3.5 (1.4) 3.3 (1.6) .000 
Because it improves parties and cele-
brations 
2.0 (1.3) 3.1 (1.5) 3.1 (1.5) .000 
To be sociable 2.1 (1.4) 2.6 (1.6) 2.9 (1.6) .000 
To celebrate a special occasion with 
friends 
2.0 (1.3) 2.8 (1.4) 2.4 (1.4) .000 
Because I feel more self-confident and 
sure of myself 
2.3 (1.5) 1.8 (1.1) 1.8 (1.2) .000 
TOTAL 2.1 (1.0) 2.8 (1.0) 2.6 (1.0) .000 
CONFORMITY     
To be liked 1.6 (1.1) 1.2 (0.7) 1.1 (0.6) .000 
To fit in with the group I like 1.9 (1.3) 1.5 (0.9) 1.3 (0.7) .000 
So I won't feel left out 1.8 (1.2) 1.3 (0.7) 1.1 (0.5) .000 
TOTAL 1.7 (1.1) 1.3 (0.6) 1.2 (0.5) .000 
EXPANSION     
To expand my awareness 2.3 (1.4) 2.7 (1.6) 2.6 (1.6) .001 
To understand things differently 2.1 (1.4) 2.4 (1.5) 2.5 (1.5) .002 
To be more open to experiences 2.2 (1.4) 2.7 (1.5) 2.6 (1.5) .000 
To know myself better 1.8 (1.3) 2.1 (1.4) 2.3 (1.5) .000 
Because it helps me to more creative 
and original 
1.8 (1.2) 2.0 (1.3) 2.0 (1.3) .040 
TOTAL 2.0 (0.9) 2.4 (1.1) 2.4 (1.2) .000 
ROUTINE     
Out of boredom 2.6 (1.5) 1.7 (1.0) 1.7 (1.1) .000 
Out of habit 3.0 (1.7) 1.6 (1.1) 1.8 (1.2) .000 
TOTAL 2.8 (1.2) 1.7 (0.9) 1.8 (1.0) .000 
ADDED ITEMS     
Poor quality of other (traditional) drugs 2.5 (1.6) 1.5 (0.9) 1.8 (1.3) .000 
Price 2.5 (1.6) 1.5 (1.1) 1.8 (1.2) .000 
Alleged legality 1.8 (1.3) 1.4 (0.8) 1.6 (1.2) .000 
Expecting different or new experiences 
(regarding drug effects) 
2.6 (1.5) 3.1 (1.5) 2.8 (1.5) .000 
Non-detectability 1.9 (1.4) 1.3 (0.8) 1.5 (1.1) .000 
Low availability of other (traditional) 
drugs 
2.4 (1.5) 1.4 (0.9) 1.8 (1.3) .000 
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Table 19 Side effects and problems from NPS use among marginalised, night life and online communi-
ty recent NPS users 
 
MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
ACUTE UNPLEASANT SIDE EFFECTS     
increased heart rate / palpitation 57.5% 37.7% 35.8% .000 
headaches 51.5% 26.6% 18.9% .000 
nausea / vomiting 40,6% 28,4% 25,0% .000 
stomach ache 38.0% 18.2% 12.8% .000 
dizziness 44.7% 29.2% 20.7% .000 
muscle cramps 33.1% 15.0% 12.7% .000 
loss of consciousness / coma 23.3% 9.9% 6.7% .000 
anxiety / horror trips 47.7% 25.5% 21.2% .000 
shortness of breath 36.8% 16.0% 13.1% .000 
hyperthermia 33.5% 17.8% 17.7% .000 
aggression / violence 35.7% 11.1% 4.9% .000 
paranoia 52.3% 21.9% 17.7% .000 
other 4.1% 4.9% 6.3% .221 
TOTAL 85.3% 58.8% 51.0% .000 
MID- OR LONG-TERM PROBLEMS     
addiction / withdrawal / craving 46.2% 7.4% 12.1% .000 
depression 43.2% 13.6% 14.5% .000 
paranoid disorders 38.7% 9.6% 8.2% .000 
weight loss 46.2% 9.6% 9.5% .000 
harms of injecting 26.7% 0.5% 0.8% .000 
other mental problems 15.8% 6.3% 8.6% .000 
other physical problems 12.4% 4.2% 6.4% .000 
TOTAL 70.3% 28.4% 30.9% .000 
SOCIAL PROBLEMS     
conflict at school, university, etc. 6.8% 4.3% 4.7% .277 
conflict at work 12.0% 5.6% 3.8% .000 
conflicts with partner or family 45.9% 13.6% 12.8% .000 
problems regarding housing 42.5% 3.7% 3.1% .000 
legal problems 35.7% 6.2% 5.5% .000 
other 3.0% 1.1% 1.7% .117 
TOTAL 69.1% 22.1% 22.2% .000 
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Table 20 Preventive strategies suggested by marginalised, night life and online community recent NPS 
users 
 MARGINALISED 
n = 266 
NIGHT LIFE 
n = 647 
ONLINE 
n = 2.110 
 
p 
MOST EFFECTIVE STRATEGY     
information and prevention campaigns 42.9% 54.1% 60.4% .000 
treatment and rehabilitation of users 48.1% 23.0% 31.8% .000 
tough measures against dealers 30.5% 11.4% 8.1% .000 
making drugs legal 36.1% 58.9% 76.0% .000 
reduction of poverty / unemployment 38.7% 19.9% 20.7% .000 
tough measures against users 4.1% 3.9% 2.6% .118 
offering more entertainment for young 29.7% 33.2% 21.1% .000 
other 7.9% 5.1% 8.9% .008 
SPECIAL ATTENTION NEEDED BY PROFS     
lawmakers 7.1% 10.2% 6.7% .000 
doctors 11.3% 22.4% 31.3%  
social workers / drug help 11.3% 29.2% 19.7%  
police 7.5% 2.9% 1.3%  
other professionals 8.6% 8.7% 6.1%  
no special attention by profs needed 54.1% 26.6% 34.8%  
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Appendix B Questionnaire 
When using this questionnaire, please include the following citation in your publication: 
 
Benschop, A., Bujalski, M., Dabrowska, K., Demetrovics, Z., Egger, D., Felinczi, K., Henriques, S., 
Kalo, Z., Kamphausen, G., Korf, D.J., Nabben, T., Silva, J.P., Van Hout, M.C., Werse, B., Wells, J., 
Wieczorek, L. & Wouters, M. (2017) New Psychoactive Substances: transnational project on different 
user groups, user characteristics, extent and patterns of use, market dynamics, and best practices in 
prevention. NPS-transnational Project (HOME/2014/JDRU/AG/DRUG/7077). 
 




















